Track market-moving stories before they get noisy

AT&T (T +0.56%) is part of a cellphone oligopoly in the United States. Essentially, the telecom giant and its main competitors dominate the sector, making it difficult for a newcomer to break in. However, that hasn't stopped companies from trying, including cable operators offering bundled services and, perhaps, even Space Exploration Corporation's (SPCX +2.22%) Starlink. Here's how investors should view AT&T's ability to maintain its well-above-market 4.4% dividend yield as more companies try to break into the lucrative cellphone market.

Competition has always been intense The first thing to consider when looking at AT&T's business is the competitive landscape. It has always been intense, as the members of the cellphone oligopoly fight tooth and nail for market share. There's a good reason for that, however: customer revenues tend to be annuity-like. That provides a solid foundation for paying the dividend. And while the involvement of cable companies and SpaceX increases competition, AT&T should be able to hold its own as a business.

Image source: Getty Images.

That big picture view of the situation, however, doesn't mean it will be able to continue paying its dividend at the current level. Most investors assessing dividend support will look to the payout ratio to determine whether the company can continue paying nearly $2 billion in dividends each quarter. The 36% trailing 12-month payout ratio suggests the answer is yes.

Today's Change

(

0.56

%) $

0.14

Current Price

$

25.29

But that $2 billion in dividends number came from the cash flow statement, not the income statement, where earnings live. This is because earnings aren't what pay the dividend; cash flow is. When you compare the dividend to cash flow, using the cash dividend payout ratio, you get a slightly lower coverage rate of 45%. That, however, still looks like ample coverage.

AT&T paid less in dividends year over year There's another factor to consider here, as well. AT&T uses its cash flow for many purposes, including buying back shares. In the first half of 2026, it repurchased $4.669 billion worth of stock. The reduced share count benefited the company by lowering its dividend outlay, which dropped from $4.135 billion in the first half of 2025 to $3.973 billion in the same period of 2026. So the dividend is actually on even stronger footing now than it was just a year ago. If you are a dividend investor, there doesn't appear to be a material reason to worry about AT&T's dividend right now.

Wolfspeed (WOLF -2.24%) had been one of the hottest stocks in the market this spring, surging on hopes that it could become the next AI winner.

The rise coincided with a bullish report from Substack publication Citrini Research, which had earlier come into prominence after publishing a thought piece about how artificial intelligence (AI) would negatively impact software-as-a-service (SaaS) stocks, helping sink that sector.

However, after its shares reached more than $80, Wolfspeed stock has come crashing back down to earth, retracing the big move it had made in May following Citrini pumping the stock. Its latest pullback coincided with another disheartening earnings report on Aug. 19.

Image source: The Motley Fool

Negative gross margins and weak sales persist Wolfspeed emerged from bankruptcy last fall, wiping out some expensive debt and finding itself on better footing. However, many of the issues that pushed it into bankruptcy in the first place remain. The chief among them is negative gross margins.

Wolfspeed positioned itself as the leader in silicon carbide (SiC) powered chips. The company constructed expensive manufacturing plants to build out a vertically integrated supply chain. SiC has superior heat-conducting properties compared to typical silicon chips, and thus initially was projected to play a major role in the electric vehicle (EV) market.

However, the company ran into severe execution bottlenecks and market headwinds. The move to larger 200mm wafers proved to be more technically challenging than imagined, while EV demand started to slow. Meanwhile, Tesla decided to greatly reduce its use of SiC moving forward.

That left Wolfspeed with severely underutilized, brand-spanking-new plants, which is one of the worst things a semiconductor company can experience. It is also one of the reasons why most traditional silicon-based chipmakers use a fabless model and rely on third-party foundries like Taiwan Semiconductor Manufacturing.

Today's Change

(

-2.24

%) $

-0.59

Current Price

$

25.76

Wolfspeed's operational issues persisted in its fiscal fourth quarter, with the company seeing negative gross margins of 25% due to continued plant underutilization. Adjusted gross margins, meanwhile, came in at negative 19.9%, a 70-basis point sequential improvement.

Revenue growth continues to be an issue, with revenue falling 24% year over year from $197 million to $149.6 million. It was also a slight sequential decline from $150.2 million in fiscal Q3 and right in the middle of its $140 million to $160 million outlook.

While auto revenue remained soft, the company did see its AI data center revenue more than double year over year and rise 20% sequentially. It highlighted a few new design wins with power supply companies, while saying SiC content was increasing in data centers due to the transition to 800-volt architectures.

Given its negative gross margins and $600 million in net debt, cash flow remains an issue. The company has negative operating cash flow of $180.3 million over the past nine months after exiting bankruptcy, and negative free cash flow of $253.7 million. It will look to retire some high-interest debt to help with its cash flow moving forward.

Looking ahead, the company once again guided for quarterly revenue to be in the $140 million to $160 million range and for gross margins to remain negative. It said it would likely need revenue to reach $800 million in revenue for its adjusted gross margins to break even.

Even after coming out of bankruptcy, Wolfspeed still finds itself in a precarious position. Negative gross margins and free cash flow are never great signs for a business, and the company will need to see a meaningful acceleration in sales just to get to breakeven gross margins, which isn't exactly a huge accomplishment.

That said, the transition to 800-volt architectures in AI data centers is a legitimate structural shift, and the opportunity for SiC is both real and accelerating. So, there is the potential for a big turnaround in the stock. This makes Wolfspeed an interesting, but highly speculative, stock to buy at this point.

Emerald Investment Advisers LLC acquired a new stake in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 25,314 shares of the medical instruments supplier’s stock, valued at approximately $3,711,000. Emerald Investment Advisers LLC owned about 0.10% of ICU Medical as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently bought and sold shares of the company. Allworth Financial LP acquired a new position in shares of ICU Medical in the 2nd quarter valued at $26,000. Hilton Head Capital Partners LLC acquired a new stake in shares of ICU Medical during the fourth quarter worth $32,000. Covestor Ltd grew its stake in shares of ICU Medical by 22.1% during the fourth quarter. Covestor Ltd now owns 696 shares of the medical instruments supplier’s stock worth $99,000 after purchasing an additional 126 shares during the period. Strs Ohio increased its holdings in ICU Medical by 60.0% in the fourth quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock valued at $114,000 after purchasing an additional 300 shares during the last quarter. Finally, Rockefeller Capital Management L.P. increased its holdings in ICU Medical by 21.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 146 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Analysts Set New Price Targets A number of equities analysts have issued reports on ICUI shares. Weiss Ratings upgraded ICU Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 23rd. Zacks Research cut ICU Medical from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 28th. Jefferies Financial Group upgraded shares of ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. Sanford C. Bernstein downgraded shares of ICU Medical to a “market perform” rating in a research note on Monday, June 15th. Finally, Wall Street Zen raised shares of ICU Medical from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Two research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $192.80.

Check Out Our Latest Analysis on ICU Medical ICU Medical Price Performance ICUI stock opened at $182.84 on Friday. The stock has a 50-day moving average price of $160.85 and a two-hundred day moving average price of $143.13. ICU Medical, Inc. has a 1 year low of $112.50 and a 1 year high of $192.85. The stock has a market cap of $4.57 billion, a PE ratio of 154.95, a price-to-earnings-growth ratio of 2.31 and a beta of 0.74. The company has a current ratio of 2.43, a quick ratio of 1.21 and a debt-to-equity ratio of 0.56.

ICU Medical (NASDAQ:ICUI – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.46. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%.The company had revenue of $547.88 million during the quarter, compared to analysts’ expectations of $533.44 million. During the same period in the prior year, the firm earned $2.10 earnings per share. ICU Medical’s revenue for the quarter was up .5% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. Equities analysts forecast that ICU Medical, Inc. will post 7.19 EPS for the current fiscal year.

Insider Buying and Selling at ICU Medical In other news, insider Ben Sousa sold 2,250 shares of the company’s stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $178.32, for a total transaction of $401,220.00. Following the sale, the insider owned 3,076 shares in the company, valued at $548,512.32. This represents a 42.25% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Elisha W. Finney sold 378 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $182.48, for a total transaction of $68,977.44. Following the transaction, the director owned 4,871 shares in the company, valued at $888,860.08. This represents a 7.20% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 16,974 shares of company stock valued at $3,085,844. Corporate insiders own 2.10% of the company’s stock.

About ICU Medical (Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Recommended Stories Five stocks we like better than ICU Medical 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Danske Bank A S bought a new stake in Armstrong World Industries, Inc. (NYSE:AWI – Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 3,311 shares of the construction company’s stock, valued at approximately $531,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in Armstrong World Industries in the second quarter worth approximately $827,239,000. Bank of Montreal Can increased its holdings in shares of Armstrong World Industries by 18,679.7% during the fourth quarter. Bank of Montreal Can now owns 1,279,086 shares of the construction company’s stock valued at $244,433,000 after acquiring an additional 1,272,275 shares in the last quarter. Norges Bank acquired a new position in shares of Armstrong World Industries during the fourth quarter worth approximately $107,716,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Armstrong World Industries by 33,007.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 473,104 shares of the construction company’s stock worth $90,410,000 after purchasing an additional 471,675 shares during the period. Finally, SurgoCap Partners LP acquired a new position in shares of Armstrong World Industries during the fourth quarter worth approximately $72,020,000. 98.93% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In Several analysts recently issued reports on the stock. Evercore set a $200.00 price target on shares of Armstrong World Industries in a research report on Tuesday, April 28th. Jefferies Financial Group restated a “hold” rating and set a $190.00 price target on shares of Armstrong World Industries in a research note on Wednesday, July 29th. Weiss Ratings downgraded shares of Armstrong World Industries from a “buy (b)” rating to a “buy (b-)” rating in a report on Thursday, June 4th. Finally, UBS Group reaffirmed a “neutral” rating and issued a $203.00 price objective on shares of Armstrong World Industries in a research note on Wednesday, July 29th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Armstrong World Industries has an average rating of “Moderate Buy” and an average target price of $213.00.

Read Our Latest Report on AWI Armstrong World Industries Stock Performance Shares of Armstrong World Industries stock opened at $179.01 on Friday. The company has a market cap of $7.56 billion, a PE ratio of 24.52, a price-to-earnings-growth ratio of 1.74 and a beta of 1.16. Armstrong World Industries, Inc. has a 52 week low of $150.28 and a 52 week high of $206.08. The business has a 50 day moving average price of $166.21 and a 200-day moving average price of $169.27. The company has a quick ratio of 1.06, a current ratio of 1.52 and a debt-to-equity ratio of 0.58.

Armstrong World Industries (NYSE:AWI – Get Free Report) last announced its earnings results on Tuesday, July 28th. The construction company reported $2.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.25 by $0.11. Armstrong World Industries had a return on equity of 37.35% and a net margin of 18.60%.The company had revenue of $472.00 million for the quarter, compared to analysts’ expectations of $461.67 million. During the same quarter in the previous year, the firm earned $2.09 earnings per share. Armstrong World Industries’s quarterly revenue was up 11.2% on a year-over-year basis. Armstrong World Industries has set its FY 2026 guidance at 8.300-8.500 EPS. Equities analysts anticipate that Armstrong World Industries, Inc. will post 8.39 earnings per share for the current fiscal year.

Armstrong World Industries declared that its board has authorized a share repurchase plan on Tuesday, July 21st that permits the company to buyback $800.00 million in outstanding shares. This buyback authorization permits the construction company to purchase up to 12.3% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.

Armstrong World Industries Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Wednesday, August 5th were paid a $0.339 dividend. The ex-dividend date was Wednesday, August 5th. This represents a $1.36 annualized dividend and a dividend yield of 0.8%. Armstrong World Industries’s dividend payout ratio is presently 18.63%.

Armstrong World Industries Company Profile (Free Report)

Armstrong World Industries, Inc is a leading global manufacturer of commercial ceiling and wall solutions. The company offers a diverse portfolio of acoustical, decorative and specialty ceiling systems designed to enhance interior environments in offices, healthcare facilities, schools, retail outlets and other non-residential settings. Through its focus on performance, aesthetics and sustainability, Armstrong World Industries addresses both functional and design requirements for architects, contractors and building owners.

Armstrong’s product range includes mineral fiber, fiberglass, wood wool, metal and stone wool ceiling panels, as well as suspension and grid systems.

Featured Stories Five stocks we like better than Armstrong World Industries 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Armstrong World Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Armstrong World Industries and related companies with MarketBeat.com's FREE daily email newsletter.

The race for Federal Aviation Administration (FAA) certification won't determine the long-term winner, because Joby Aviation (JOBY -0.66%) and Archer Aviation (ACHR +3.45%) have vastly different business models that will evolve. However, achieving FAA certification will immediately de-risk the stocks and change the investment narrative from "burning cash in risky development" to "investing cash to scale growth" for both companies. Certification matters, and here's what to look out for in the process.

The key number to look out for Given that the FAA won't make a certification decision until each company's electric vertical take-off and landing (eVTOL) aircraft has completed aircraft-level "for credit" testing, investors should look for each company to complete this process 100%. This is the process by which FAA pilots conduct or witness extensive test flights of an eVTOL under a Type Inspection Authorization (TIA). Before achieving TIA, companies must build an FAA-conforming eVTOL and test it with their own pilots.

Today's Change

(

-0.66

%) $

-0.05

Current Price

$

7.53

If you are wondering who is ahead, Joby is generally considered ahead because it conducted its first FAA-conforming eVTOL flight in early March. Moreover, CEO JoeBen Bevirt outlined that "We now have five of our electric air taxis in the air, including our first FAA-conforming aircraft" on the recent earnings call.

In comparison, Archer's management has not said it has produced an FAA-conforming aircraft. Still, CEO Adam Goldstein did say, "We're actively working with the FAA on for-credit testing this year." That said, readers should note that this could refer to component-level rather than aircraft-level testing of an FAA-conforming aircraft.

Whichever way you take it, Joby is slightly ahead.

Image source: Joby Aviation.

Why FAA certification matters more to Archer Joby's focus is on becoming a vertically integrated transportation-as-a-service (TaaS) company that builds, owns, and operates its eVTOLs, and Archer's focus is on being an original equipment manufacturer (OEM). While the distinction is somewhat blurred (Joby will also sell some aircraft, and Archer has some TaaS plans of its own, such as becoming an airport shuttle service), it helps explain why early FAA certification is arguably more of a game changer for Archer. Simply put, Archer is likely to generate more upfront revenue and cash flow from OEM sales. In contrast, Joby's business model entails building a TaaS network before it receives significant recurring revenue from ride services.

Today's Change

(

3.45

%) $

0.21

Current Price

$

6.30

What investors should look for in both companies For Joby, the key milestone to follow as it moves toward 100% credit testing is achieving FAA TIA, which will allow final testing to begin. For Archer, it's building its FAA-conforming eVTOL and having its pilots fly it. Joby looks likely to achieve FAA certification first (though the situation is highly dynamic), but arguably, certification will unlock more value for Archer Aviation. Winning the race is important, but think of it as the first leg in a relay race rather than a one-off sprint.

Callan Family Office LLC purchased a new stake in Manulife Financial Corp (NYSE:MFC – Free Report) (TSE:MFC) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 88,157 shares of the financial services provider’s stock, valued at approximately $3,571,000.

Several other institutional investors also recently made changes to their positions in MFC. UBS Group AG grew its position in Manulife Financial by 10.0% during the fourth quarter. UBS Group AG now owns 4,016,230 shares of the financial services provider’s stock valued at $145,709,000 after acquiring an additional 363,963 shares during the period. Generali Asset Management SPA SGR increased its stake in Manulife Financial by 1,092.1% during the fourth quarter. Generali Asset Management SPA SGR now owns 51,632 shares of the financial services provider’s stock worth $1,873,000 after acquiring an additional 47,301 shares during the last quarter. Canerector Inc. increased its stake in Manulife Financial by 27.0% during the first quarter. Canerector Inc. now owns 800,000 shares of the financial services provider’s stock worth $28,000 after acquiring an additional 170,000 shares during the last quarter. Swiss National Bank raised its holdings in shares of Manulife Financial by 25.7% in the 1st quarter. Swiss National Bank now owns 5,645,600 shares of the financial services provider’s stock worth $194,191,000 after purchasing an additional 1,154,200 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of Manulife Financial by 183.7% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 11,702,230 shares of the financial services provider’s stock worth $402,969,000 after purchasing an additional 7,577,711 shares during the period. 52.56% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets MFC has been the subject of a number of research reports. TD Securities reiterated a “buy” rating on shares of Manulife Financial in a report on Thursday, August 6th. Zacks Research downgraded shares of Manulife Financial from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 15th. Scotiabank restated an “outperform” rating on shares of Manulife Financial in a report on Friday, August 7th. Royal Bank Of Canada lifted their price target on shares of Manulife Financial from $55.00 to $67.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Finally, Weiss Ratings upgraded shares of Manulife Financial from a “buy (a-)” rating to a “buy (a)” rating in a research note on Wednesday. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $59.00.

Get Our Latest Stock Analysis on Manulife Financial Manulife Financial Price Performance NYSE:MFC opened at $42.54 on Friday. The business’s 50-day moving average is $42.48 and its two-hundred day moving average is $38.90. Manulife Financial Corp has a 12 month low of $29.77 and a 12 month high of $45.33. The firm has a market capitalization of $70.70 billion, a PE ratio of 15.87 and a beta of 0.84.

Manulife Financial (NYSE:MFC – Get Free Report) (TSE:MFC) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.01. Manulife Financial had a return on equity of 16.68% and a net margin of 9.99%.The company had revenue of $2.22 billion for the quarter, compared to analysts’ expectations of $7.28 billion. During the same quarter in the previous year, the firm posted $0.95 earnings per share. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. Equities analysts anticipate that Manulife Financial Corp will post 3.03 EPS for the current year.

Manulife Financial Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Monday, September 21st. Investors of record on Friday, August 21st will be issued a dividend of $0.485 per share. This represents a $1.94 annualized dividend and a dividend yield of 4.6%. The ex-dividend date is Friday, August 21st. Manulife Financial’s dividend payout ratio (DPR) is presently 53.36%.

(Free Report)

Manulife Financial Corporation is a multinational insurance and financial services company headquartered in Toronto, Ontario. Founded in the late 19th century as The Manufacturers Life Insurance Company, Manulife provides a broad range of financial products and services to individual and institutional clients. Its core businesses include life and health insurance, retirement and pension solutions, wealth and asset management, and group benefits.

In wealth and asset management, Manulife operates through Manulife Investment Management and offers mutual funds, segregated funds, institutional asset management, and retirement plan solutions.

Recommended Stories Five stocks we like better than Manulife Financial 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit? Want to see what other hedge funds are holding MFC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Manulife Financial Corp (NYSE:MFC – Free Report) (TSE:MFC).

Receive News & Ratings for Manulife Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manulife Financial and related companies with MarketBeat.com's FREE daily email newsletter.

Callan Family Office LLC purchased a new position in Modine Manufacturing Company (NYSE:MOD – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,937 shares of the auto parts company’s stock, valued at approximately $2,920,000.

Other hedge funds have also recently made changes to their positions in the company. Lazard Asset Management LLC purchased a new stake in shares of Modine Manufacturing during the first quarter valued at about $1,722,000. Ranger Investment Management L.P. bought a new stake in shares of Modine Manufacturing in the 1st quarter valued at about $15,557,000. Allspring Global Investments Holdings LLC grew its position in shares of Modine Manufacturing by 253.2% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 306,005 shares of the auto parts company’s stock worth $68,230,000 after buying an additional 219,373 shares during the last quarter. DUTCH ASSET Corp grew its position in shares of Modine Manufacturing by 122.2% in the 1st quarter. DUTCH ASSET Corp now owns 18,709 shares of the auto parts company’s stock worth $4,055,000 after buying an additional 10,290 shares during the last quarter. Finally, Lisanti Capital Growth LLC bought a new position in shares of Modine Manufacturing during the 2nd quarter worth approximately $6,402,000. 95.23% of the stock is currently owned by hedge funds and other institutional investors.

Modine Manufacturing Stock Performance Shares of Modine Manufacturing stock opened at $198.03 on Friday. The firm has a market capitalization of $10.52 billion, a P/E ratio of 74.45, a PEG ratio of 0.65 and a beta of 1.71. The company has a quick ratio of 1.22, a current ratio of 2.04 and a debt-to-equity ratio of 0.39. The company has a 50 day moving average price of $232.44 and a 200 day moving average price of $236.03. Modine Manufacturing Company has a 52 week low of $111.18 and a 52 week high of $323.25.

Modine Manufacturing (NYSE:MOD – Get Free Report) last released its earnings results on Wednesday, July 29th. The auto parts company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.26. Modine Manufacturing had a net margin of 4.28% and a return on equity of 25.59%. The company had revenue of $874.10 million for the quarter, compared to the consensus estimate of $878.69 million. During the same quarter in the previous year, the firm earned $0.95 EPS. Modine Manufacturing’s revenue was up 28.0% compared to the same quarter last year. Sell-side analysts expect that Modine Manufacturing Company will post 7.65 EPS for the current year. Analysts Set New Price Targets A number of equities research analysts recently commented on MOD shares. Glj Research reissued a “buy” rating and set a $428.00 target price on shares of Modine Manufacturing in a research report on Monday, June 1st. DA Davidson reaffirmed a “buy” rating and issued a $330.00 price target on shares of Modine Manufacturing in a report on Monday, June 22nd. Wall Street Zen downgraded Modine Manufacturing from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. Weiss Ratings upgraded Modine Manufacturing from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 28th. Finally, UBS Group raised their price objective on Modine Manufacturing to $310.00 and gave the stock a “buy” rating in a research report on Wednesday, May 27th. Seven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $320.14.

Check Out Our Latest Research Report on MOD

Insider Transactions at Modine Manufacturing In other news, VP Brian Jon Agen sold 38,282 shares of Modine Manufacturing stock in a transaction on Thursday, June 18th. The shares were sold at an average price of $295.17, for a total transaction of $11,299,697.94. Following the completion of the sale, the vice president directly owned 66,343 shares in the company, valued at approximately $19,582,463.31. The trade was a 36.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric D. Ashleman sold 15,000 shares of the business’s stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $288.54, for a total transaction of $4,328,100.00. Following the sale, the director directly owned 42,350 shares in the company, valued at $12,219,669. This trade represents a 26.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 54,302 shares of company stock worth $15,928,759. Company insiders own 1.92% of the company’s stock.

(Free Report)

Modine Manufacturing Company (NYSE:MOD) is a global provider of thermal management solutions serving automotive, commercial transportation, heavy-duty off-highway, industrial, HVAC and refrigeration markets. The company designs, manufactures, tests and markets a broad array of heat-transfer products that manage temperature and energy efficiency for engines, power electronics and building climate control systems.

Its product portfolio includes heat exchangers, condensers, radiators, evaporators, charge air coolers, fan systems and associated controls.

Further Reading Five stocks we like better than Modine Manufacturing 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Modine Manufacturing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modine Manufacturing and related companies with MarketBeat.com's FREE daily email newsletter.

Amazon (AMZN -0.57%) has emerged from a challenging period with high growth and massive opportunities. Its artificial intelligence (AI) spend, which provoked an exodus from the stock last year, is paying off, and the market is starting to appreciate it again.

Amazon stock is up 15% year to date, edging out the S&P 500's 13% gain, but it still looks cheap; it's trading at 21.3 times forward, 1-year earnings, a very slight premium to the S&P 500 average of 20.4.

Image source: Amazon.

Amazon has massive opportunities CEO Andy Jassy has maintained over the past few years that the AI spend is necessary to harness the incredible opportunities in AI. Amazon has a first-mover's edge and the most to gain, since it's the largest cloud company in the world.

At times, Jassy has appeared surprised by the intense, negative market reaction to what seems logical and necessary. He has reiterated many times that this is the biggest opportunity since the internet, and that there's going to be a shift to the cloud. Well, that time has come, and Amazon is ready.

Although Amazon has been reporting strong growth for a while, the second quarter was a standout. Sales increased 20% over last year, all the more impressive now that Amazon is the largest company in the world by sales. It's highly profitable as well, and operating income rose from $10 billion last year to $27.5 billion this year.

Amazon Web Services (AWS), the cloud segment, is doing a lot of the heavy lifting. Sales for the cloud business increased more than 37% year over year, the highest in 18 quarters. That's in turn driven by AI. AWS offers a vast platform for AI development with a large array of features and products for every budget. It serves a huge client base of top-tier companies like Warner Bros. Discovery, Snowflake, and Moody's, all of which it signed new deals in the second quarter. AWS operating income increased from $10.2 billion to $16.6 billion, accounting for more than 60% of the total.

It also has a fast-growing chip company which would be one of the largest chip businesses in the world on its own, and it signed multi-year commitments with Anthropic and OpenAI in addition to many more clients in the second quarter. Amazon's Graviton5 chip has 25% better compute performance than Graviton4, and the line already has 30% to 40% better compute performance than similar chips. Revenue commitments for Graviton increased threefold sequentially in the second quarter.

Today's Change

(

-0.57

%) $

-1.48

Current Price

$

258.63

Investors shouldn't ignore progress in e-commerce, though. Amazon added 80 U.S. cities to its ultra-fast delivery service, which gets orders to customer in less than 30 minutes. E-commerce is still Amazon's bread and butter, and the money coming in from the core e-commerce segment provides the foundation for the company to launch new businesses like AWS and the brand-new Amazon Leo satellite broadband business, which competes with Space Exploration Technologies' Starlink business. E-commerce is still growing by double digits, and if not outshined by AI, it would be impressive on its own.

Is Amazon stock a bargain? So why is Amazon stock so cheap?

When a company is as big as Amazon, or any of the mega-cap companies, the market sees a cap on growth. Although Amazon is growing by double digits, it's not the same kind of astronomical growth as a young upstart. So while there's a long opportunity ahead, it's going to come more slowly and more steadily. That's the only reason I can think of for why Amazon stock looks so cheap today.

Investors should keep that in mind when considering Amazon stock. The company can still outperform the market and create shareholder value, but it's not going to deliver the same life-changing wealth it did in the past.

Czech National Bank boosted its holdings in shares of Microsoft Corporation (NASDAQ:MSFT – Free Report) by 4.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,114,417 shares of the software giant’s stock after purchasing an additional 92,079 shares during the period. Microsoft makes up approximately 4.3% of Czech National Bank’s holdings, making the stock its 3rd biggest position. Czech National Bank’s holdings in Microsoft were worth $788,720,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in shares of Microsoft by 2.3% during the fourth quarter. Vanguard Group Inc. now owns 717,942,580 shares of the software giant’s stock worth $347,211,391,000 after purchasing an additional 15,955,898 shares during the period. State Street Corp boosted its position in shares of Microsoft by 2.1% in the 4th quarter. State Street Corp now owns 306,150,608 shares of the software giant’s stock valued at $148,060,557,000 after purchasing an additional 6,388,930 shares during the period. Geode Capital Management LLC increased its stake in Microsoft by 1.1% in the 4th quarter. Geode Capital Management LLC now owns 182,618,400 shares of the software giant’s stock worth $88,056,019,000 after purchasing an additional 1,911,142 shares in the last quarter. Morgan Stanley increased its stake in Microsoft by 0.8% in the 4th quarter. Morgan Stanley now owns 121,220,561 shares of the software giant’s stock worth $58,624,690,000 after purchasing an additional 980,439 shares in the last quarter. Finally, Norges Bank acquired a new stake in Microsoft during the 4th quarter worth about $50,664,631,000. 71.13% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In A number of research firms have commented on MSFT. Arete Research upped their price objective on shares of Microsoft from $730.00 to $870.00 and gave the company a “buy” rating in a research note on Tuesday, May 5th. Wedbush restated an “outperform” rating and set a $575.00 price target on shares of Microsoft in a report on Wednesday, May 13th. President Capital upped their price target on shares of Microsoft from $500.00 to $520.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. The Goldman Sachs Group reissued a “buy” rating and set a $640.00 target price on shares of Microsoft in a research note on Thursday, July 30th. Finally, Barclays reduced their target price on Microsoft from $545.00 to $512.00 and set an “overweight” rating for the company in a report on Thursday, July 30th. Forty-two analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $560.27.

Read Our Latest Stock Report on MSFT Microsoft Stock Performance MSFT stock opened at $483.24 on Friday. The firm has a 50 day simple moving average of $419.61 and a 200 day simple moving average of $409.30. Microsoft Corporation has a 52 week low of $349.20 and a 52 week high of $553.72. The stock has a market cap of $3.59 trillion, a P/E ratio of 26.91, a P/E/G ratio of 1.56 and a beta of 1.11. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.22 and a current ratio of 1.23.

Microsoft (NASDAQ:MSFT – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The software giant reported $4.74 earnings per share for the quarter, beating the consensus estimate of $4.24 by $0.50. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The firm had revenue of $90.01 billion for the quarter, compared to analyst estimates of $87.62 billion. During the same quarter in the prior year, the business earned $3.65 EPS. The company’s revenue for the quarter was up 17.7% compared to the same quarter last year. Research analysts anticipate that Microsoft Corporation will post 19.59 earnings per share for the current fiscal year.

Microsoft Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Thursday, August 20th will be given a dividend of $0.91 per share. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $3.64 dividend on an annualized basis and a yield of 0.8%. Microsoft’s dividend payout ratio (DPR) is presently 20.27%.

Microsoft News Summary Here are the key news stories impacting Microsoft this week:

Positive Sentiment: Microsoft is reportedly preparing to launch its Maia 300 AI accelerator as soon as this fall and is discussing production with TSMC. Developing proprietary chips could reduce long-term reliance on Nvidia, improve supply-chain control, and support Microsoft’s expanding AI infrastructure. Microsoft’s Betting Big on Its Own AI Chips Positive Sentiment: Meta has reportedly become one of Microsoft’s largest Azure AI customers, spending hundreds of millions of dollars annually and consuming substantial computing capacity. The relationship reinforces evidence that enterprise demand is translating into Azure revenue. Meta Emerges as a Major Microsoft Azure AI Client Positive Sentiment: Microsoft raised its quarterly dividend to $0.91 per share, while Azure revenue reportedly surpassed $100 billion. Analysts and financial commentators also highlighted a roughly $678 billion backlog and continued strong demand for cloud and AI services. Microsoft Raises Dividend as AI Capital Spending Hits Record Levels Neutral Sentiment: Microsoft approved the Horizon 1 Texas data-center project involving IREN, potentially expanding capacity available for AI workloads. The development is strategically relevant, although the near-term financial benefit to Microsoft remains unclear. Microsoft Accepts Horizon 1 Negative Sentiment: Annual capital spending has climbed nearly 80% to about $115.9 billion, while free cash flow declined. Investors remain focused on whether AI revenue growth will generate adequate returns on this spending. Microsoft Spent $115.9 Billion on AI Negative Sentiment: TCI Management reportedly exited its Microsoft position and increased its Alphabet stake, adding a notable institutional-selling signal. Separately, commentary warned that Microsoft’s valuation depends on optimistic earnings forecasts, while higher bond yields could reduce the present value of future AI profits. TCI Exits Microsoft Insiders Place Their Bets In related news, EVP Takeshi Numoto sold 4,810 shares of Microsoft stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $496.48, for a total value of $2,388,068.80. Following the completion of the sale, the executive vice president owned 42,677 shares of the company’s stock, valued at approximately $21,188,276.96. The trade was a 10.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Judson Althoff sold 10,000 shares of the company’s stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $487.89, for a total transaction of $4,878,900.00. Following the completion of the sale, the chief executive officer owned 100,447 shares of the company’s stock, valued at $49,007,086.83. This represents a 9.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 37,310 shares of company stock valued at $17,256,219. Insiders own 0.03% of the company’s stock.

Microsoft Profile (Free Report)

Microsoft Corporation is a global technology company headquartered in Redmond, Washington. Founded in 1975 by Bill Gates and Paul Allen, Microsoft develops, licenses and supports a broad range of software products, services and devices for consumers, enterprises and governments worldwide. Its operations span personal computing, productivity software, cloud infrastructure, enterprise applications, developer tools and gaming.

Microsoft’s product portfolio includes the Windows operating system and the Microsoft 365 suite of productivity and collaboration tools (Office apps, Outlook, Teams).

Read More Five stocks we like better than Microsoft 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.

Cornerstone Advisors LLC grew its holdings in Advanced Micro Devices, Inc. (NASDAQ:AMD – Free Report) by 24.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 81,465 shares of the semiconductor manufacturer’s stock after acquiring an additional 15,753 shares during the period. Advanced Micro Devices accounts for approximately 1.6% of Cornerstone Advisors LLC’s holdings, making the stock its 13th largest position. Cornerstone Advisors LLC’s holdings in Advanced Micro Devices were worth $47,324,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in AMD. Norges Bank acquired a new position in Advanced Micro Devices during the fourth quarter valued at approximately $4,929,312,000. Jennison Associates LLC increased its holdings in shares of Advanced Micro Devices by 181.6% during the 4th quarter. Jennison Associates LLC now owns 10,910,310 shares of the semiconductor manufacturer’s stock worth $2,336,552,000 after purchasing an additional 7,035,991 shares during the period. Cardano Risk Management B.V. acquired a new position in Advanced Micro Devices in the 4th quarter valued at approximately $1,000,783,000. BlackRock Inc. lifted its position in shares of Advanced Micro Devices by 3.1% during the 2nd quarter. BlackRock Inc. now owns 150,301,510 shares of the semiconductor manufacturer’s stock worth $87,311,650,000 after buying an additional 4,535,126 shares during the period. Finally, Wellington Management Group LLP lifted its holdings in shares of Advanced Micro Devices by 335.9% during the third quarter. Wellington Management Group LLP now owns 4,847,825 shares of the semiconductor manufacturer’s stock valued at $784,330,000 after acquiring an additional 3,735,807 shares during the period. Institutional investors and hedge funds own 71.34% of the company’s stock.

Trending Headlines about Advanced Micro Devices Here are the key news stories impacting Advanced Micro Devices this week:

Positive Sentiment: BMO initiated coverage of AMD with a buy recommendation, adding to bullish Wall Street sentiment toward the semiconductor sector and AMD’s AI opportunity. BMO Buy Ratings for Semiconductor Stocks Positive Sentiment: AMD continues to show stronger and more consistent revenue growth than Arm Holdings. Its latest quarter included record revenue of $11.54 billion, up 50.1% year over year, and earnings that exceeded analyst expectations. AMD and Arm Revenue Comparison Positive Sentiment: Reports that Google may collaborate with AMD on its next-generation TPU could represent a meaningful design win and broaden AMD’s relationships with hyperscalers. Coatue Management’s new position, valued at approximately $55.8 million, also signals institutional interest in the AI trade. Google Reportedly Working With AMD on a TPU Neutral Sentiment: AMD is increasingly viewed as Nvidia’s most credible AI-chip challenger, particularly with its Helios platform, but investors remain focused on whether it can narrow Nvidia’s ecosystem and market-share advantages. AMD and Nvidia AI Competition Negative Sentiment: Google’s expanding custom-chip program, including its relationship with Marvell, could increase competition for AI-inference workloads. A report that SpaceX selected Nvidia’s Vera Rubin platform reinforces concerns that AMD is still losing some high-profile AI infrastructure opportunities. SpaceX Selects Nvidia AI Infrastructure Negative Sentiment: CEO Lisa Su and SVP Ava Hahn sold shares totaling roughly $8.7 million. The transactions were made under pre-arranged Rule 10b5-1 plans, limiting their signaling value, but the sales may still weigh on sentiment after AMD’s substantial rally. AMD Insider Stock Sale Negative Sentiment: Valuation remains a risk: AMD trades at a very high earnings multiple, leaving the stock vulnerable to profit-taking or disappointment if AI growth slows or fails to meet aggressive expectations. AMD Valuation Analysis Analysts Set New Price Targets A number of research analysts have recently issued reports on AMD shares. Citigroup upgraded shares of Advanced Micro Devices from a “market perform” rating to a “buy” rating in a research note on Wednesday, July 22nd. Oppenheimer cut Advanced Micro Devices from a “market perform” rating to a “market perform” rating in a report on Wednesday, May 6th. Raymond James Financial began coverage on shares of Advanced Micro Devices in a report on Wednesday, May 6th. They set a “market perform” rating for the company. Roth Capital increased their price target on shares of Advanced Micro Devices from $500.00 to $650.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Advanced Micro Devices in a report on Monday, August 3rd. Three investment analysts have rated the stock with a Strong Buy rating, thirty-two have given a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Advanced Micro Devices currently has an average rating of “Moderate Buy” and a consensus price target of $546.95. Get Our Latest Analysis on Advanced Micro Devices

Advanced Micro Devices stock opened at $473.25 on Friday. The company’s 50-day moving average price is $511.40 and its two-hundred day moving average price is $375.55. The stock has a market cap of $772.57 billion, a P/E ratio of 121.66 and a beta of 2.48. Advanced Micro Devices, Inc. has a twelve month low of $149.22 and a twelve month high of $584.73. The company has a quick ratio of 1.91, a current ratio of 2.61 and a debt-to-equity ratio of 0.03.

Advanced Micro Devices (NASDAQ:AMD – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The semiconductor manufacturer reported $1.66 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.04. Advanced Micro Devices had a return on equity of 12.30% and a net margin of 15.58%.The firm had revenue of $11.54 billion for the quarter, compared to analyst estimates of $11.31 billion. During the same period in the prior year, the firm posted $0.48 EPS. The company’s revenue for the quarter was up 50.1% on a year-over-year basis. As a group, analysts expect that Advanced Micro Devices, Inc. will post 6.44 EPS for the current year.

Insider Activity In other news, EVP Paul Darren Grasby sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $514.91, for a total transaction of $7,723,650.00. Following the transaction, the executive vice president directly owned 117,687 shares of the company’s stock, valued at approximately $60,598,213.17. This trade represents a 11.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Ava Hahn sold 2,993 shares of Advanced Micro Devices stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $488.69, for a total transaction of $1,462,649.17. Following the completion of the sale, the senior vice president owned 26,623 shares of the company’s stock, valued at approximately $13,010,393.87. The trade was a 10.11% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 210,763 shares of company stock worth $99,912,107. Insiders own 0.50% of the company’s stock.

Advanced Micro Devices Profile (Free Report)

Advanced Micro Devices, Inc (NASDAQ: AMD) is a global semiconductor company that designs and sells microprocessors, graphics processors, chipsets and adaptive computing solutions for a broad set of markets. The company’s product portfolio includes consumer and commercial CPUs under the Ryzen and Threadripper brands, data center processors under the EPYC brand, and Radeon graphics processing units for gaming and professional visualization. AMD also offers semi-custom system-on-chip (SoC) products for gaming consoles and other specialized applications, and provides supporting software and platform technologies for OEMs, cloud service providers and end users.

Founded in 1969, AMD has evolved from a supplier of logic chips into a diversified, fabless semiconductor designer.

Featured Stories Five stocks we like better than Advanced Micro Devices 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Advanced Micro Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Micro Devices and related companies with MarketBeat.com's FREE daily email newsletter.

Family Wealth Partners LLC trimmed its holdings in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 62.6% in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,859 shares of the computer hardware maker’s stock after selling 3,110 shares during the quarter. Family Wealth Partners LLC’s holdings in NVIDIA were worth $372,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Lifetime Wealth Management P.C. bought a new position in shares of NVIDIA during the 4th quarter valued at $26,000. Longview Financial Advisors Inc. bought a new position in NVIDIA in the first quarter valued at about $27,000. Longfellow Investment Management Co. LLC boosted its position in NVIDIA by 47.9% in the second quarter. Longfellow Investment Management Co. LLC now owns 207 shares of the computer hardware maker’s stock worth $33,000 after purchasing an additional 67 shares during the last quarter. Phillip James Consulting Co. purchased a new position in NVIDIA in the first quarter worth about $40,000. Finally, Spurstone Advisory Services LLC bought a new stake in shares of NVIDIA during the 2nd quarter valued at about $40,000. Hedge funds and other institutional investors own 65.27% of the company’s stock.

Insider Activity In other news, Director Mark A. Stevens sold 885,000 shares of NVIDIA stock in a transaction that occurred on Thursday, June 18th. The stock was sold at an average price of $210.17, for a total value of $186,000,450.00. Following the completion of the transaction, the director owned 5,207,271 shares in the company, valued at approximately $1,094,412,146.07. The trade was a 14.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John Dabiri sold 625 shares of the business’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $214.00, for a total transaction of $133,750.00. Following the transaction, the director owned 14,163 shares in the company, valued at $3,030,882. This trade represents a 4.23% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,901,125 shares of company stock valued at $410,583,015 in the last ninety days. Insiders own 3.94% of the company’s stock.

Key Headlines Impacting NVIDIA Here are the key news stories impacting NVIDIA this week: Positive Sentiment: NVIDIA is reportedly in advanced talks to invest several hundred million dollars in Cloverleaf Infrastructure, a developer of U.S. data-center power and infrastructure. The move could help address the electricity bottleneck limiting AI capacity while strengthening NVIDIA’s role in projects that use its systems. Nvidia in Talks to Invest in Data-Center Power Developer Cloverleaf Infrastructure Positive Sentiment: Analyst support remains strong before earnings. BMO named NVIDIA its top semiconductor pick with a $340 price target, while Jefferies reportedly expects revenue to exceed consensus by roughly $3 billion. Consensus forecasts call for approximately $91 billion of quarterly revenue, supported by Blackwell and broader AI infrastructure demand. Nvidia stock dubbed top pick ahead of Q2 earnings Positive Sentiment: Reports that SpaceX is standardizing its AI infrastructure on NVIDIA chips reinforce the company’s competitive position and could support demand for its next-generation Vera Rubin platform. NVIDIA is also exploring a potential partnership or acquisition involving South Korean AI-chip designer Rebellions, indicating continued investment in its AI ecosystem. NVIDIA Could Snap up Korean AI Chip Startup Rebellions Neutral Sentiment: NVIDIA’s proposed investment in Cloverleaf follows other efforts to finance AI infrastructure and convert future GPU capacity into a financeable asset. The strategy could accelerate deployments, but it also exposes NVIDIA to capital-allocation and customer-financing risks. Nvidia Makes Another Bet on the AI Power Bottleneck Negative Sentiment: Investors are weighing possible competitive and product risks. NVIDIA is reportedly testing Rubin Ultra configurations with less high-bandwidth memory than originally planned, while Microsoft is preparing its own Maia 300 AI chip. These developments could raise questions about performance, supply availability and long-term customer diversification. NVIDIA and AMD: Rubin Ultra memory reports Negative Sentiment: NVIDIA denied a report that it plans small-batch shipments of a China-specific AI chip by year-end, removing a potential near-term catalyst. Analysts also say any renewed China H200 sales may have only a limited effect on revenue. Nvidia to ship AI chip for China by year-end Negative Sentiment: Higher Treasury yields and warnings from investors such as Michael Burry that AI data-center financing may be excessive are adding valuation pressure ahead of a high-expectation earnings event. Analyst Upgrades and Downgrades Several analysts recently issued reports on the stock. Craig Hallum boosted their target price on shares of NVIDIA from $245.00 to $275.00 and gave the company a “buy” rating in a research report on Thursday, May 21st. Seaport Research Partners increased their price target on shares of NVIDIA from $140.00 to $180.00 and gave the stock a “sell” rating in a research report on Thursday, May 21st. Mizuho set a $300.00 price target on shares of NVIDIA in a research note on Thursday, May 21st. Itau BBA Securities cut their price objective on shares of NVIDIA from $256.00 to $218.00 in a research report on Wednesday, June 24th. Finally, Argus upped their price objective on NVIDIA from $220.00 to $270.00 and gave the stock a “buy” rating in a research note on Thursday, May 21st. Three investment analysts have rated the stock with a Strong Buy rating, forty-nine have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $308.01.

Read Our Latest Report on NVIDIA

NVIDIA Stock Performance Shares of NASDAQ NVDA opened at $214.75 on Friday. NVIDIA Corporation has a 52-week low of $164.07 and a 52-week high of $236.54. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.85 and a current ratio of 3.44. The firm’s fifty day moving average is $207.47 and its two-hundred day moving average is $199.52. The company has a market cap of $5.20 trillion, a P/E ratio of 32.89, a P/E/G ratio of 0.43 and a beta of 2.23.

NVIDIA (NASDAQ:NVDA – Get Free Report) last posted its earnings results on Wednesday, May 20th. The computer hardware maker reported $1.87 EPS for the quarter, beating analysts’ consensus estimates of $1.76 by $0.11. NVIDIA had a return on equity of 96.94% and a net margin of 62.97%.The firm had revenue of $81.61 billion during the quarter, compared to the consensus estimate of $78.42 billion. During the same period in the prior year, the company earned $0.81 EPS. The company’s quarterly revenue was up 85.2% compared to the same quarter last year. As a group, analysts anticipate that NVIDIA Corporation will post 8.8 EPS for the current fiscal year.

NVIDIA announced that its Board of Directors has authorized a share buyback plan on Wednesday, May 20th that permits the company to buyback $80.00 billion in shares. This buyback authorization permits the computer hardware maker to purchase up to 1.5% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s leadership believes its stock is undervalued.

NVIDIA Company Profile (Free Report)

NVIDIA Corporation, founded in 1993 and headquartered in Santa Clara, California, is a global technology company that designs and develops graphics processing units (GPUs) and system-on-chip (SoC) technologies. Co-founded by Jensen Huang, who serves as president and chief executive officer, along with Chris Malachowsky and Curtis Priem, NVIDIA has grown from a graphics-focused chipmaker into a broad provider of accelerated computing hardware and software for multiple industries.

The company’s product portfolio spans discrete GPUs for gaming and professional visualization (marketed under the GeForce and NVIDIA RTX lines), high-performance data center accelerators used for AI training and inference (including widely adopted platforms such as the A100 and H100 series), and Tegra SoCs for automotive and edge applications.

Recommended Stories Five stocks we like better than NVIDIA 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit? Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.

Danske Bank A S acquired a new position in shares of Bank of America Corporation (NYSE:BAC – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 4,423,418 shares of the financial services provider’s stock, valued at approximately $252,046,000. Danske Bank A S owned 0.06% of Bank of America as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in BAC. Gables Capital Management Inc. purchased a new stake in Bank of America in the second quarter valued at approximately $5,182,000. Investmark Advisory Group LLC acquired a new position in Bank of America during the second quarter worth $220,000. Wealthfront Advisers LLC acquired a new position in Bank of America during the second quarter worth $56,700,000. Global Strategic Investment Solutions LLC purchased a new position in shares of Bank of America during the second quarter worth $259,000. Finally, Foster & Motley Inc. purchased a new position in shares of Bank of America during the second quarter worth $792,000. Institutional investors and hedge funds own 70.71% of the company’s stock.

Bank of America Price Performance Bank of America stock opened at $61.73 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.82 and a debt-to-equity ratio of 1.23. The company has a fifty day simple moving average of $60.60 and a 200-day simple moving average of $54.67. The stock has a market cap of $431.66 billion, a P/E ratio of 14.16, a price-to-earnings-growth ratio of 0.98 and a beta of 1.17. Bank of America Corporation has a 12-month low of $46.12 and a 12-month high of $65.22.

Bank of America (NYSE:BAC – Get Free Report) last posted its earnings results on Tuesday, July 14th. The financial services provider reported $1.21 EPS for the quarter, beating the consensus estimate of $1.13 by $0.08. Bank of America had a return on equity of 12.20% and a net margin of 17.56%.The firm had revenue of $31.56 billion for the quarter, compared to analyst estimates of $30.78 billion. During the same quarter in the prior year, the company posted $0.89 earnings per share. Bank of America’s revenue for the quarter was up 19.6% compared to the same quarter last year. Equities analysts expect that Bank of America Corporation will post 4.68 EPS for the current fiscal year. Bank of America Increases Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Friday, September 4th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 4th. This represents a $1.28 annualized dividend and a dividend yield of 2.1%. This is an increase from Bank of America’s previous quarterly dividend of $0.28. Bank of America’s payout ratio is currently 25.69%.

Analyst Ratings Changes Several research firms recently issued reports on BAC. Weiss Ratings reiterated a “buy (b)” rating on shares of Bank of America in a report on Tuesday, July 21st. Oppenheimer cut Bank of America from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 30th. Truist Financial lifted their target price on Bank of America from $64.00 to $65.00 and gave the company a “buy” rating in a research report on Wednesday, July 15th. JPMorgan Chase & Co. boosted their price target on shares of Bank of America from $62.50 to $68.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 29th. Finally, Keefe, Bruyette & Woods increased their price target on shares of Bank of America from $67.00 to $70.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 15th. Twenty-one investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $64.08.

View Our Latest Stock Report on BAC

Key Bank of America News Here are the key news stories impacting Bank of America this week:

Positive Sentiment: Bank of America’s active participation in the August bond market demonstrates continued access to wholesale funding and allows it to extend maturities through senior unsecured offerings. Its latest quarterly results also showed strong earnings and revenue growth, providing a fundamental counterweight to near-term concerns. Bank of America’s Stock Market Signal Flashes Warning Neutral Sentiment: Bank of America increased its indirect stake in Turkish industrial technology company Hidropar to 5.386%. The disclosure indicates portfolio or client-related investment activity, but it is not expected to materially affect BAC’s earnings. Bank of America Lifts Indirect Stake in Hidropar to 5.386% Neutral Sentiment: Bank of America crossed a disclosure threshold in Smith & Nephew, reflecting an updated shareholding. The move is unlikely to have a meaningful direct impact on BAC’s common stock. Smith & Nephew Discloses Updated Bank of America Shareholding Neutral Sentiment: Bank of America’s analysts issued views on HP, Home Depot and Nvidia. These calls may generate research-related attention, but they do not materially change BAC’s own fundamentals. Bank of America Sends Warning on HP Stock Negative Sentiment: A market commentary warns that crowded positioning in Bank of America could make any broader-market pullback sharper. Separate analysis questions whether BAC is undervalued after its recent bond issuance, while noting recent short-term share-price weakness. These factors are weighing on sentiment despite the bank’s solid earnings profile. Bank of America’s Stock Market Signal Flashes Warning Is Bank of America Undervalued? Negative Sentiment: Analysis of Bank of America preferred stock suggests that more attractive alternatives may exist than Series GG. While this primarily affects preferred securities, it can modestly temper sentiment toward BAC’s capital-raising instruments. Bank of America Preferreds: Better Propositions Available Than Series GG (Free Report)

Bank of America Corporation is a multinational financial services company headquartered in Charlotte, North Carolina. It provides a broad array of banking, investment, asset management and related financial and risk management products and services to individual consumers, small- and middle-market businesses, large corporations, governments and institutional investors. The firm operates through consumer banking, global wealth and investment management, global banking and markets businesses, offering capabilities across lending, deposits, payments, advisory and capital markets.

Its consumer-facing offerings include checking and savings accounts, mortgages, home equity lending, auto loans, credit cards and small business banking, supported by a nationwide branch network and digital channels.

Featured Stories Five stocks we like better than Bank of America 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Bank of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bank of America and related companies with MarketBeat.com's FREE daily email newsletter.

Foster & Motley Inc. bought a new stake in Bank of America Corporation (NYSE:BAC – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 13,893 shares of the financial services provider’s stock, valued at approximately $792,000.

Several other institutional investors have also recently made changes to their positions in the company. Cypress Asset Management Inc. TX bought a new stake in Bank of America in the second quarter worth about $1,045,000. Main Street Financial Solutions LLC bought a new position in shares of Bank of America during the second quarter valued at approximately $4,255,000. Rayburn West Financial Services LLC bought a new position in shares of Bank of America during the second quarter valued at approximately $5,139,000. First National Bank of Omaha purchased a new stake in shares of Bank of America in the second quarter worth approximately $4,926,000. Finally, Timothy G. Youngquist 2020 Irrevocable Trust raised its holdings in shares of Bank of America by 598.8% in the second quarter. Timothy G. Youngquist 2020 Irrevocable Trust now owns 16,583 shares of the financial services provider’s stock worth $945,000 after buying an additional 14,210 shares during the period. Institutional investors own 70.71% of the company’s stock.

Analyst Ratings Changes A number of equities analysts recently issued reports on BAC shares. Jefferies Financial Group restated a “buy” rating and set a $75.00 price objective on shares of Bank of America in a report on Tuesday, July 14th. Daiwa Securities Group increased their target price on Bank of America from $58.00 to $61.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Weiss Ratings reiterated a “buy (b)” rating on shares of Bank of America in a research report on Tuesday, July 21st. JPMorgan Chase & Co. lifted their target price on Bank of America from $62.50 to $68.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 29th. Finally, Morgan Stanley boosted their target price on shares of Bank of America from $61.00 to $67.00 and gave the company an “overweight” rating in a research note on Monday, June 29th. Twenty-one investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Bank of America presently has a consensus rating of “Moderate Buy” and an average price target of $64.08.

Read Our Latest Report on BAC Bank of America Stock Performance Bank of America stock opened at $61.73 on Friday. The company has a debt-to-equity ratio of 1.23, a quick ratio of 0.82 and a current ratio of 0.83. The company has a market capitalization of $431.66 billion, a PE ratio of 14.16, a P/E/G ratio of 0.98 and a beta of 1.17. The company has a 50 day moving average price of $60.60 and a 200-day moving average price of $54.67. Bank of America Corporation has a fifty-two week low of $46.12 and a fifty-two week high of $65.22.

Bank of America (NYSE:BAC – Get Free Report) last announced its quarterly earnings data on Tuesday, July 14th. The financial services provider reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.08. The company had revenue of $31.56 billion for the quarter, compared to analysts’ expectations of $30.78 billion. Bank of America had a return on equity of 12.20% and a net margin of 17.56%.Bank of America’s revenue was up 19.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.89 earnings per share. As a group, equities analysts forecast that Bank of America Corporation will post 4.68 earnings per share for the current year.

Bank of America Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Friday, September 4th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 4th. This represents a $1.28 annualized dividend and a dividend yield of 2.1%. This is a positive change from Bank of America’s previous quarterly dividend of $0.28. Bank of America’s dividend payout ratio (DPR) is currently 25.69%.

Key Stories Impacting Bank of America Here are the key news stories impacting Bank of America this week:

Positive Sentiment: Bank of America’s active participation in the August bond market demonstrates continued access to wholesale funding and allows it to extend maturities through senior unsecured offerings. Its latest quarterly results also showed strong earnings and revenue growth, providing a fundamental counterweight to near-term concerns. Bank of America’s Stock Market Signal Flashes Warning Neutral Sentiment: Bank of America increased its indirect stake in Turkish industrial technology company Hidropar to 5.386%. The disclosure indicates portfolio or client-related investment activity, but it is not expected to materially affect BAC’s earnings. Bank of America Lifts Indirect Stake in Hidropar to 5.386% Neutral Sentiment: Bank of America crossed a disclosure threshold in Smith & Nephew, reflecting an updated shareholding. The move is unlikely to have a meaningful direct impact on BAC’s common stock. Smith & Nephew Discloses Updated Bank of America Shareholding Neutral Sentiment: Bank of America’s analysts issued views on HP, Home Depot and Nvidia. These calls may generate research-related attention, but they do not materially change BAC’s own fundamentals. Bank of America Sends Warning on HP Stock Negative Sentiment: A market commentary warns that crowded positioning in Bank of America could make any broader-market pullback sharper. Separate analysis questions whether BAC is undervalued after its recent bond issuance, while noting recent short-term share-price weakness. These factors are weighing on sentiment despite the bank’s solid earnings profile. Bank of America’s Stock Market Signal Flashes Warning Is Bank of America Undervalued? Negative Sentiment: Analysis of Bank of America preferred stock suggests that more attractive alternatives may exist than Series GG. While this primarily affects preferred securities, it can modestly temper sentiment toward BAC’s capital-raising instruments. Bank of America Preferreds: Better Propositions Available Than Series GG Bank of America Company Profile (Free Report)

Bank of America Corporation is a multinational financial services company headquartered in Charlotte, North Carolina. It provides a broad array of banking, investment, asset management and related financial and risk management products and services to individual consumers, small- and middle-market businesses, large corporations, governments and institutional investors. The firm operates through consumer banking, global wealth and investment management, global banking and markets businesses, offering capabilities across lending, deposits, payments, advisory and capital markets.

Its consumer-facing offerings include checking and savings accounts, mortgages, home equity lending, auto loans, credit cards and small business banking, supported by a nationwide branch network and digital channels.

Read More Five stocks we like better than Bank of America 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Bank of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bank of America and related companies with MarketBeat.com's FREE daily email newsletter.

Emerald Investment Advisers LLC boosted its holdings in Target Corporation (NYSE:TGT – Free Report) by 97.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,867 shares of the retailer’s stock after buying an additional 8,315 shares during the period. Emerald Investment Advisers LLC’s holdings in Target were worth $2,203,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Target by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 58,212,397 shares of the retailer’s stock worth $5,690,262,000 after acquiring an additional 286,499 shares during the period. BlackRock Inc. bought a new stake in shares of Target during the 2nd quarter valued at $5,054,604,000. State Street Corp lifted its stake in shares of Target by 0.3% in the 4th quarter. State Street Corp now owns 37,772,533 shares of the retailer’s stock valued at $3,692,265,000 after purchasing an additional 124,468 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Target by 3.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 17,065,926 shares of the retailer’s stock valued at $1,668,194,000 after purchasing an additional 561,898 shares during the period. Finally, Bank of New York Mellon Corp bought a new position in shares of Target in the 2nd quarter worth $831,466,000. 79.73% of the stock is currently owned by institutional investors and hedge funds.

Target Trading Up 4.5% Shares of NYSE TGT opened at $165.35 on Friday. Target Corporation has a twelve month low of $83.44 and a twelve month high of $165.48. The stock has a market cap of $75.10 billion, a price-to-earnings ratio of 17.17, a P/E/G ratio of 2.43 and a beta of 0.97. The company has a quick ratio of 0.30, a current ratio of 0.99 and a debt-to-equity ratio of 0.80. The company’s fifty day moving average is $140.82 and its 200-day moving average is $128.01.

Target (NYSE:TGT – Get Free Report) last released its quarterly earnings data on Wednesday, August 19th. The retailer reported $4.11 EPS for the quarter, beating analysts’ consensus estimates of $2.35 by $1.76. The business had revenue of $26.54 billion during the quarter, compared to analysts’ expectations of $26.13 billion. Target had a net margin of 4.08% and a return on equity of 23.23%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.05 EPS. Target has set its FY 2026 guidance at 9.900-10.900 EPS. Equities research analysts predict that Target Corporation will post 8.84 EPS for the current year. Target Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Wednesday, August 12th will be paid a $1.16 dividend. The ex-dividend date of this dividend is Wednesday, August 12th. This is a positive change from Target’s previous quarterly dividend of $1.14. This represents a $4.64 dividend on an annualized basis and a yield of 2.8%. Target’s payout ratio is presently 48.18%.

Key Target News Here are the key news stories impacting Target this week:

Positive Sentiment: Improved outlook: Target raised its fiscal 2026 earnings guidance to $9.90–$10.90 per share, citing stronger sales, digital growth, category performance and momentum that may extend beyond tariff-related benefits. Target Raises View as Growth Momentum Extends Beyond Tariff Tailwinds Positive Sentiment: Strong quarterly performance: Target reported $4.11 in quarterly EPS versus the $2.35 consensus estimate, while revenue of $26.54 billion exceeded expectations and increased 5.3% year over year. Traffic rose 3.6%, supported by merchandising improvements and better execution. Target Q2 Earnings Call Highlights Higher Sales Outlook and Traffic Positive Sentiment: Analyst support: RBC raised its price target to $178 and maintained an outperform rating. Other analysts also lifted targets following the earnings report, reinforcing the bullish reaction. Target Stock Climbs After Analysts Boost Price Targets Neutral Sentiment: Citigroup and TD Cowen raised their price targets but retained neutral/hold ratings, suggesting the stock’s valuation may already reflect much of the improved outlook. Negative Sentiment: A $994 million tariff refund significantly boosted second-quarter profitability, raising questions about how sustainable the earnings jump will be. Elevated valuation and execution risks could limit additional upside. Target Raises 2026 Guidance as Tariff Refunds Boost Q2 Profitability Negative Sentiment: Zacks Research downgraded Target from “strong buy” to “hold,” providing a counterweight to the broader analyst optimism. Insider Activity In other Target news, insider Cara A. Sylvester sold 10,000 shares of the stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $125.89, for a total value of $1,258,900.00. Following the completion of the sale, the insider directly owned 45,930 shares in the company, valued at $5,782,127.70. This represents a 17.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.13% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades A number of equities research analysts recently commented on the company. BMO Capital Markets lifted their price objective on Target from $150.00 to $160.00 and gave the stock a “market perform” rating in a research note on Thursday. Evercore set a $170.00 target price on Target in a research note on Thursday. Argus set a $150.00 target price on Target in a report on Friday, May 22nd. Guggenheim raised their target price on Target from $150.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Morgan Stanley restated an “overweight” rating on shares of Target in a research report on Thursday. Eleven analysts have rated the stock with a Buy rating, eighteen have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $159.52.

Check Out Our Latest Research Report on TGT

Target Company Profile (Free Report)

Target Corporation (NYSE: TGT) is a U.S.-based general merchandise retailer headquartered in Minneapolis, Minnesota. The company operates a network of full-line and small-format stores across the United States alongside a national e-commerce platform and mobile app. Target’s retail assortment spans apparel, home goods, electronics, groceries and household essentials, plus beauty, baby and pet categories. The firm complements national brands with a portfolio of owned and exclusive labels and partnerships that help differentiate its merchandise assortment.

Target traces its roots to the Dayton Company, founded by George Dayton in 1902; the Target discount chain was launched in 1962 and the parent company later adopted the Target Corporation name.

Further Reading Five stocks we like better than Target 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit? Want to see what other hedge funds are holding TGT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Target Corporation (NYSE:TGT – Free Report).

Receive News & Ratings for Target Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target and related companies with MarketBeat.com's FREE daily email newsletter.

EP Wealth Advisors LLC purchased a new position in shares of General Motors Company (NYSE:GM – Free Report) (TSE:GMM.U) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 26,170 shares of the auto manufacturer’s stock, valued at approximately $2,017,000.

Several other hedge funds have also made changes to their positions in GM. Tsfg LLC boosted its stake in shares of General Motors by 5.7% in the fourth quarter. Tsfg LLC now owns 2,241 shares of the auto manufacturer’s stock valued at $182,000 after purchasing an additional 120 shares during the period. Bogart Wealth LLC increased its stake in General Motors by 15.6% during the 4th quarter. Bogart Wealth LLC now owns 905 shares of the auto manufacturer’s stock worth $74,000 after buying an additional 122 shares during the period. Sumitomo Life Insurance Co. lifted its holdings in General Motors by 0.7% during the 4th quarter. Sumitomo Life Insurance Co. now owns 19,477 shares of the auto manufacturer’s stock worth $1,584,000 after buying an additional 127 shares in the last quarter. UMB Bank n.a. lifted its holdings in General Motors by 2.0% during the 4th quarter. UMB Bank n.a. now owns 6,887 shares of the auto manufacturer’s stock worth $560,000 after buying an additional 136 shares in the last quarter. Finally, Waddell & Associates LLC boosted its position in General Motors by 1.3% in the 4th quarter. Waddell & Associates LLC now owns 10,737 shares of the auto manufacturer’s stock valued at $873,000 after buying an additional 137 shares during the period. Institutional investors and hedge funds own 92.67% of the company’s stock.

More General Motors News Here are the key news stories impacting General Motors this week:

Positive Sentiment: Analysts lifted some earnings expectations. Zacks Research raised its Q4 2026 EPS forecast to $2.56 from $2.52, while another analyst reportedly boosted full-year FY2026 estimates. GM’s current consensus EPS forecast is $13.29. FY2026 EPS Estimates for General Motors Boosted by Analyst Positive Sentiment: GM continues to benefit from better-than-expected earnings. The automaker’s latest quarterly results exceeded both EPS and revenue estimates, with earnings of $3.57 per share on $48.03 billion in revenue. The stock has also gained since that report, supporting near-term investor momentum. General Motors Up Since Last Earnings Report Positive Sentiment: Valuation expectations improved. One analysis raised GM’s fair-value estimate from $94.81 to $100.04 per share following mixed reactions to its second-quarter results and guidance. General Motors Fair Value Rises Neutral Sentiment: GM is generating higher profits while selling fewer vehicles. That strategy contrasts with Toyota’s volume-focused approach, which is reportedly bringing the rival closer to GM’s long-standing U.S. sales leadership. The development highlights both GM’s improved profitability and potential longer-term market-share risk. GM and Toyota U.S. Auto Sales Negative Sentiment: NHTSA opened a probe covering nearly 1 million GM pickups and SUVs. Regulators are reviewing 997,743 vehicles after 499 complaints involving engine failures, including concerns that an earlier recall may not have resolved the problem. The investigation raises potential risks of additional recalls, repair costs, legal exposure and reputational damage. NHTSA Probe Into GM Vehicles Negative Sentiment: Longer-term earnings estimates remain mixed. Zacks Research lowered its Q1 2028 EPS forecast to $3.09 from $3.20, signaling some caution about GM’s future earnings trajectory despite the improved near-term estimate. Wall Street Analyst Weigh In Several research firms have commented on GM. Wedbush restated an “outperform” rating and issued a $95.00 price target on shares of General Motors in a research note on Monday, May 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of General Motors in a research note on Friday, July 17th. Benchmark reiterated a “buy” rating on shares of General Motors in a report on Tuesday, July 21st. The Goldman Sachs Group boosted their target price on General Motors from $91.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Finally, Mizuho cut their price target on General Motors from $105.00 to $100.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $101.41. Get Our Latest Stock Report on General Motors

Insiders Place Their Bets In other General Motors news, President Mark L. Reuss sold 71,079 shares of General Motors stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $89.97, for a total transaction of $6,394,977.63. Following the completion of the sale, the president directly owned 92,293 shares of the company’s stock, valued at $8,303,601.21. The trade was a 43.51% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Grant Michael Dixton sold 40,000 shares of the company’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $88.44, for a total value of $3,537,600.00. Following the transaction, the executive vice president directly owned 54,992 shares of the company’s stock, valued at approximately $4,863,492.48. This represents a 42.11% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,241,401 shares of company stock worth $106,313,695. 0.44% of the stock is owned by corporate insiders.

General Motors Stock Up 2.1% Shares of General Motors stock opened at $87.98 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.14 and a debt-to-equity ratio of 1.42. General Motors Company has a 52-week low of $54.33 and a 52-week high of $91.85. The company has a market capitalization of $77.20 billion, a P/E ratio of 44.43, a P/E/G ratio of 0.40 and a beta of 1.30. The company has a 50 day moving average of $82.01 and a 200 day moving average of $79.58.

General Motors (NYSE:GM – Get Free Report) (TSE:GMM.U) last announced its quarterly earnings data on Tuesday, July 21st. The auto manufacturer reported $3.57 EPS for the quarter, beating analysts’ consensus estimates of $3.19 by $0.38. General Motors had a net margin of 1.05% and a return on equity of 18.18%. The company had revenue of $48.03 billion for the quarter, compared to the consensus estimate of $47.01 billion. During the same period in the prior year, the firm posted $2.53 EPS. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. General Motors has set its FY 2026 guidance at 12.000-14.000 EPS. As a group, research analysts forecast that General Motors Company will post 13.29 EPS for the current fiscal year.

General Motors Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Thursday, September 17th. Investors of record on Friday, September 4th will be paid a dividend of $0.18 per share. The ex-dividend date is Friday, September 4th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. General Motors’s payout ratio is presently 36.36%.

General Motors Profile (Free Report)

General Motors Company (NYSE: GM) is a global automotive manufacturer headquartered in Detroit, Michigan, that designs, builds and sells cars, trucks, crossovers and electric vehicles, and provides related parts and services. Founded in 1908, GM has long been one of the world’s largest automakers and has evolved into a multi-brand company whose primary marques include Chevrolet, GMC, Cadillac and Buick. Beyond vehicle manufacturing, GM’s operations encompass vehicle financing, connected services and advanced mobility initiatives.

GM develops and markets a broad portfolio of products and technologies, including internal-combustion and battery-electric vehicles, vehicle components and on-board connectivity services.

Featured Articles Five stocks we like better than General Motors 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for General Motors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for General Motors and related companies with MarketBeat.com's FREE daily email newsletter.

Aljian Capital Management LLC acquired a new position in shares of Starbucks Corporation (NASDAQ:SBUX – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 24,537 shares of the coffee company’s stock, valued at approximately $2,507,000. Starbucks makes up approximately 0.5% of Aljian Capital Management LLC’s portfolio, making the stock its 25th biggest holding.

Other hedge funds have also modified their holdings of the company. Sunbelt Securities Inc. increased its stake in Starbucks by 1.0% in the 1st quarter. Sunbelt Securities Inc. now owns 9,473 shares of the coffee company’s stock worth $849,000 after purchasing an additional 97 shares in the last quarter. Webster Bank N. A. lifted its stake in Starbucks by 7.8% during the second quarter. Webster Bank N. A. now owns 1,396 shares of the coffee company’s stock valued at $143,000 after buying an additional 101 shares in the last quarter. Nilsine Partners LLC boosted its holdings in shares of Starbucks by 1.0% in the second quarter. Nilsine Partners LLC now owns 10,039 shares of the coffee company’s stock worth $1,026,000 after buying an additional 101 shares during the period. Beta Wealth Group Inc. increased its position in shares of Starbucks by 1.7% in the second quarter. Beta Wealth Group Inc. now owns 6,216 shares of the coffee company’s stock worth $635,000 after acquiring an additional 102 shares in the last quarter. Finally, Elgethun Capital Management increased its position in shares of Starbucks by 9.4% in the second quarter. Elgethun Capital Management now owns 1,219 shares of the coffee company’s stock worth $125,000 after acquiring an additional 105 shares in the last quarter. 72.29% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Starbucks Here are the key news stories impacting Starbucks this week:

Positive Sentiment: Starbucks is eliminating more than 200 corporate positions as part of a broader restructuring and approximately $2 billion cost-reduction effort. Lower overhead could support profitability if the company maintains service levels and directs more resources toward its stores. The reductions do not involve cafe closures. Starbucks trims corporate ranks as coffeehouse investments deliver Positive Sentiment: Recent market commentary highlights Starbucks’ roughly 25% 2026 gain and suggests investors are rewarding its operational reset and investments in the cafe experience. The rally follows the company’s latest quarterly earnings beat, with adjusted EPS of $0.85 versus a $0.66 consensus estimate and revenue above expectations. Neutral Sentiment: The restructuring is relocating some corporate operations to a new, approximately $100 million Nashville office. Around 120 Seattle employees reportedly declined the move, while another 104 roles in store design and construction are being eliminated. Management characterizes the actions as part of the restructuring winding down, but the savings and impact on execution remain to be demonstrated. Starbucks cuts another 224 Seattle jobs Negative Sentiment: Starbucks continues to face challenges in China, where domestic competitors, shifting consumer preferences and geopolitical tensions are eroding the position of major U.S. brands. China weakness could limit international growth and pressure comparable sales. Why some of America’s biggest brands are losing ground in China Negative Sentiment: The stock’s strong performance has also produced a demanding valuation, with the supplied data showing a P/E ratio above 60. Investors may require sustained earnings growth from the turnaround to justify the premium, leaving SBUX vulnerable to disappointment. Starbucks Price Performance Shares of SBUX opened at $107.08 on Friday. The business’s 50-day moving average is $104.45 and its 200-day moving average is $100.36. The company has a market capitalization of $122.07 billion, a price-to-earnings ratio of 61.54, a P/E/G ratio of 1.85 and a beta of 0.97. Starbucks Corporation has a fifty-two week low of $77.99 and a fifty-two week high of $110.51. Starbucks (NASDAQ:SBUX – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The coffee company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.66 by $0.19. Starbucks had a net margin of 5.17% and a negative return on equity of 34.10%. The business had revenue of $9.32 billion during the quarter, compared to analysts’ expectations of $9.17 billion. During the same period last year, the company posted $0.50 earnings per share. The firm’s quarterly revenue was down 1.4% compared to the same quarter last year. Starbucks has set its FY 2026 guidance at 2.550-2.650 EPS. Equities research analysts expect that Starbucks Corporation will post 2.64 earnings per share for the current fiscal year.

Starbucks Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Friday, August 14th will be paid a dividend of $0.62 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $2.48 dividend on an annualized basis and a dividend yield of 2.3%. Starbucks’s dividend payout ratio (DPR) is 142.53%.

Insider Activity In other news, CEO Brady Brewer sold 2,229 shares of the business’s stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $105.99, for a total transaction of $236,251.71. Following the transaction, the chief executive officer directly owned 75,135 shares in the company, valued at $7,963,558.65. The trade was a 2.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 6,687 shares of company stock worth $681,663. Company insiders own 0.03% of the company’s stock.

Wall Street Analysts Forecast Growth Several equities research analysts recently commented on SBUX shares. Melius Research set a $110.00 price target on shares of Starbucks in a research report on Monday, August 3rd. Piper Sandler reiterated an “overweight” rating and set a $110.00 price objective on shares of Starbucks in a research report on Wednesday, April 29th. DA Davidson lifted their price objective on shares of Starbucks from $102.00 to $110.00 and gave the stock a “neutral” rating in a research report on Thursday, July 30th. Scotiabank downgraded shares of Starbucks from a “market perform” rating to an “underperform” rating in a research note on Thursday, May 14th. Finally, Evercore restated an “outperform” rating on shares of Starbucks in a report on Thursday, July 30th. Nineteen equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $110.30.

Check Out Our Latest Analysis on SBUX

Starbucks Company Profile (Free Report)

Starbucks Corporation is a global coffeehouse chain and roaster that operates, licenses and franchises coffee shops and related retail businesses. Founded in Seattle, Washington in 1971 by Jerry Baldwin, Zev Siegl and Gordon Bowker, the company grew from a single store focused on whole-bean coffee and equipment into a broad consumer-facing brand. Howard Schultz, who joined the company later and served in senior leadership roles, is widely credited with transforming Starbucks into a mass-market specialty coffee retailer and expanding its footprint internationally.

Starbucks’ core activities center on the retail sale of hot and cold specialty beverages, whole-bean and packaged coffees, teas and ready-to-drink products, along with complementary food items and merchandise such as mugs and brewing equipment.

See Also Five stocks we like better than Starbucks 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Starbucks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starbucks and related companies with MarketBeat.com's FREE daily email newsletter.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

August is closing on a market that has rewarded speculation and punished patience, which is exactly when the boring compounders start looking interesting again. The three names below are all Dividend Kings, each with more than 50 consecutive years of dividend increases, and each has just delivered results that reinforce why long-term holders keep showing up (we ranked our ten favorite Dividend Kings by valuation right now in a free report here). Two of them are trading well off their 52-week highs, and one is running hot into a World Cup catalyst. For investors thinking about positioning income portfolios before the calendar flips to September, this trio deserves a serious look.

Procter & Gamble: A 70-Year Streak at a Reset Price Procter & Gamble (NYSE:PG | PG Price Prediction) is the definition of forever-hold. The consumer staples giant just closed out fiscal 2026 with its 70th consecutive year of dividend increases and has now paid dividends for 136 straight years, going back to 1890. That is a streak that has become an institution.

The latest quarterly payout sits at $1.0885 per share, with an annualized forward dividend of $4.354. Fiscal 2026 delivered core EPS of $6.89 on $87.03 billion in revenue, and management has laid out a fiscal 2027 capital return plan of over $10 billion in dividends plus roughly $5 billion in share repurchases. Free cash flow productivity hit 100% for the year.

The bull case is straightforward. P&G owns Tide, Pampers, Gillette, Crest, Charmin, and Olay. Nine of ten product categories held or grew organic sales in fiscal 2026, and management said they are "growing share in China for the first time in 15 quarters." Shares are down 6.21% over the past year and trade at a forward P/E near 20, a rare discount for a business this durable.

The risk: fiscal 2027 carries approximately $1 billion after tax of cost headwinds from raw materials, energy, and transportation. Management warned first-quarter EPS could be "down 5% or more versus prior year." That is a real speed bump, but it is a cyclical drag on a structural compounder.

PepsiCo: 54 Years of Raises and a North American Reset PepsiCo (NASDAQ:PEP) just delivered its latest quarterly dividend of $1.48 per share, up from $1.4225, extending a streak that now sits at more than five decades of annual increases. The forward annualized payout is $5.92 per share, and the dividend yield of 4.05% is the highest of this trio.

Q2 2026 was better than the headlines suggested. Revenue came in at $24.18 billion, and reported net revenue grew 7% in the first half. CEO Ramon Laguarta highlighted the international engine: "Our international business, as you saw, continues very strong, and we were able to grow 7% accelerating." That business is "going to cross $40 billion in this year" and is now profit-accretive.

The stock has quietly turned. It is up 5.77% over the past month as investors have started to look past the North American slowdown. A forward P/E of 17 for a business with 51% return on equity is the kind of setup long-term holders live for. Plans call for roughly $8.9 billion in capital returns this year through dividends and buybacks.

The risk: North America convenience-channel weakness is real. Laguarta acknowledged the U.S. business will "gradually improve, but at a more moderate pace than we thought coming into Q2." Affordability investments will pressure near-term margins.

Coca-Cola: Momentum Meets a 60-Plus Year Dividend King Coca-Cola (NYSE:KO) is the momentum play in this group, and it is not close. Shares are up 32.06% year to date and 32.6% over the past year, with a 10.83% gain in just the last month. The current quarterly dividend of $0.53 per share annualizes to $2.12, and the next ex-dividend date is September 15, 2026.

Q2 2026 was a statement quarter. Volume grew 5%, organic revenue grew 6%, and Trademark Coca-Cola posted its strongest volume growth in 17 years, excluding COVID recovery. Fairlife grew 18%, and Powerade grew 8% globally. Management raised full-year guidance to organic revenue of approximately 5% and comparable EPS growth of 9 to 10%. Free cash flow reached approximately $6.9 billion.

The World Cup catalyst is playing out in real time. Coca-Cola activated the tournament in more than 180 markets and more than 20 million retail outlets, collecting more than 25 million first-party data points. CEO Henrique Braun said the company is "really confident that we have many levers to deliver on our objectives in 2026 and over the long term." Net debt leverage sits at 1.4 times EBITDA, below the 2 to 2.5 times target, giving management room to keep returning capital.

The risk: valuation. A forward P/E of 27 leaves less margin for error, and Q4 2026 will have six fewer days compared to the fourth quarter of 2025, which will optically pressure the reported growth. For a hold-for-life position, that is noise. For a new entry point, it is worth watching the stock into September.

Contact [email protected] for any questions or corrections.

Choreo LLC lifted its position in shares of Intel Corporation (NASDAQ:INTC – Free Report) by 6.9% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 129,387 shares of the chip maker’s stock after buying an additional 8,343 shares during the quarter. Choreo LLC’s holdings in Intel were worth $18,066,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of INTC. Sivia Capital Partners LLC boosted its holdings in Intel by 271.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 34,201 shares of the chip maker’s stock valued at $766,000 after purchasing an additional 25,001 shares during the period. United Bank acquired a new position in shares of Intel during the 2nd quarter worth approximately $205,000. Gamco Investors INC. ET AL increased its holdings in shares of Intel by 12.3% during the second quarter. Gamco Investors INC. ET AL now owns 13,737 shares of the chip maker’s stock worth $308,000 after purchasing an additional 1,508 shares during the period. NewEdge Advisors LLC increased its holdings in shares of Intel by 29.6% during the second quarter. NewEdge Advisors LLC now owns 158,277 shares of the chip maker’s stock worth $3,545,000 after purchasing an additional 36,116 shares during the period. Finally, Sei Investments Co. increased its holdings in shares of Intel by 9.9% during the second quarter. Sei Investments Co. now owns 828,352 shares of the chip maker’s stock worth $18,556,000 after purchasing an additional 74,838 shares during the period. Institutional investors own 64.53% of the company’s stock.

Insider Activity In other Intel news, CEO Lip Bu Tan purchased 105,263 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The shares were bought at an average price of $95.00 per share, for a total transaction of $9,999,985.00. Following the purchase, the chief executive officer owned 1,314,669 shares in the company, valued at approximately $124,893,555. This trade represents a 8.70% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.05% of the company’s stock.

Intel Stock Performance NASDAQ INTC opened at $90.07 on Friday. The firm’s 50 day simple moving average is $108.43 and its 200 day simple moving average is $85.00. The firm has a market capitalization of $454.31 billion, a price-to-earnings ratio of -42.69 and a beta of 2.22. The company has a current ratio of 1.60, a quick ratio of 1.25 and a debt-to-equity ratio of 0.47. Intel Corporation has a 1 year low of $23.65 and a 1 year high of $142.35. Intel (NASDAQ:INTC – Get Free Report) last announced its quarterly earnings data on Thursday, July 23rd. The chip maker reported $0.42 EPS for the quarter, beating the consensus estimate of $0.21 by $0.21. Intel had a negative net margin of 19.79% and a positive return on equity of 2.62%. The business had revenue of $16.13 billion during the quarter, compared to the consensus estimate of $14.43 billion. During the same period in the previous year, the business earned ($0.10) earnings per share. The company’s revenue was up 25.2% on a year-over-year basis. Intel has set its Q3 2026 guidance at 0.380-0.380 EPS. As a group, research analysts expect that Intel Corporation will post 1.01 earnings per share for the current fiscal year.

Intel News Roundup Here are the key news stories impacting Intel this week:

Positive Sentiment: Institutional buying provides support: Tiger Global reportedly increased its Intel position during the second quarter, adding to recent bullish interest in the company’s AI, data-center, and foundry businesses. Tiger Global Added to Its Position in Intel in Q2 Positive Sentiment: CEO purchase signals confidence: Intel CEO Lip-Bu Tan reportedly bought another 105,000 shares, a potentially favorable signal regarding management’s view of the company’s turnaround and long-term prospects. CEO Lip-Bu Tan Just Bought Another 105,000 Shares of Intel Stock Positive Sentiment: Operating momentum remains a potential catalyst: Intel’s latest reported quarter exceeded consensus EPS and revenue estimates, with revenue up 25.2% year over year. Coverage also points to a growing role for Intel in AI hardware and data-center demand. Neutral Sentiment: Government investment remains under scrutiny: Intel’s shares slipped as Commerce Secretary Howard Lutnick defended the U.S. government’s purchase of roughly 10% of the company. The investment could improve strategic and financial support, but its unusual structure has prompted investor uncertainty. Intel Stock Slips as Howard Lutnick Defends Intel Deal Negative Sentiment: Potential dilution weighs on sentiment: Reports that Intel is pursuing a stock offering of approximately $15 billion raise concerns about shareholder dilution, even if the proceeds are intended to fund expansion and capitalize on AI demand. Intel Embarks on $15 Billion Stock Offering Negative Sentiment: High-profile selling reinforces profit-taking concerns: Stanley Druckenmiller’s Duquesne Family Office reportedly exited its Intel position in the second quarter, selling about 411,400 shares while reallocating capital to other AI and robotics opportunities. Druckenmiller Dumped Micron, Intel and Broadcom Negative Sentiment: Analyst caution and valuation risk persist: Intel carries an average analyst rating of “Hold,” while some coverage argues that Nvidia and AMD offer better risk-adjusted upside. Investors remain concerned that Intel’s recent rally has priced in much of the turnaround before sustained profitability is established. Wall Street Analyst Weigh In Several equities research analysts recently issued reports on INTC shares. The Goldman Sachs Group reiterated a “neutral” rating on shares of Intel in a research note on Thursday, July 23rd. Daiwa Securities Group lowered Intel from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 4th. Weiss Ratings cut Intel from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $100.00 target price on shares of Intel in a research report on Tuesday, May 12th. Finally, Royal Bank Of Canada reissued a “sector perform” rating on shares of Intel in a report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, thirty-one have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $107.46.

Read Our Latest Analysis on INTC

About Intel (Free Report)

Intel Corporation, founded in 1968 by Robert Noyce and Gordon E. Moore and headquartered in Santa Clara, California, is a leading global designer and manufacturer of semiconductor products. The company is historically notable for introducing the first commercial microprocessor and for driving the x86 architecture that underpins many personal computers and servers. Intel’s core business spans the design, fabrication and marketing of processors, chipsets and related components for a wide range of computing applications.

Intel’s product portfolio includes client and mobile processors marketed under brands such as Intel Core and Pentium, as well as high-performance Xeon processors for data centers and cloud infrastructure.

Further Reading Five stocks we like better than Intel 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit? Want to see what other hedge funds are holding INTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intel Corporation (NASDAQ:INTC – Free Report).

Receive News & Ratings for Intel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intel and related companies with MarketBeat.com's FREE daily email newsletter.

Edmond DE Rothschild Holding S.A. reduced its position in Pfizer Inc. (NYSE:PFE – Free Report) by 8.1% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,455,651 shares of the biopharmaceutical company’s stock after selling 128,428 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in Pfizer were worth $35,052,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vermillion Wealth Management Inc. lifted its stake in shares of Pfizer by 19.4% during the first quarter. Vermillion Wealth Management Inc. now owns 2,352 shares of the biopharmaceutical company’s stock valued at $66,000 after acquiring an additional 382 shares during the period. Eagle Capital Management LLC increased its position in Pfizer by 0.3% in the first quarter. Eagle Capital Management LLC now owns 126,573 shares of the biopharmaceutical company’s stock worth $3,554,000 after purchasing an additional 390 shares during the period. Delta Financial Advisors LLC increased its position in Pfizer by 1.6% in the first quarter. Delta Financial Advisors LLC now owns 25,266 shares of the biopharmaceutical company’s stock worth $709,000 after purchasing an additional 398 shares during the period. Pines Wealth Management LLC raised its holdings in Pfizer by 4.4% during the 4th quarter. Pines Wealth Management LLC now owns 9,430 shares of the biopharmaceutical company’s stock worth $235,000 after purchasing an additional 400 shares during the last quarter. Finally, Mount Vernon Associates Inc. MD raised its holdings in Pfizer by 1.0% during the 1st quarter. Mount Vernon Associates Inc. MD now owns 41,919 shares of the biopharmaceutical company’s stock worth $1,177,000 after purchasing an additional 400 shares during the last quarter. Institutional investors own 68.36% of the company’s stock.

Wall Street Analyst Weigh In Several brokerages have recently issued reports on PFE. HSBC lowered shares of Pfizer from a “buy” rating to a “hold” rating and reduced their target price for the company from $32.00 to $28.00 in a research note on Monday, July 6th. Guggenheim cut their price objective on shares of Pfizer from $35.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, August 7th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $27.00 price objective on shares of Pfizer in a research note on Monday, July 6th. JPMorgan Chase & Co. lowered their target price on shares of Pfizer from $30.00 to $28.00 and set a “neutral” rating for the company in a report on Wednesday, July 8th. Finally, Bank of America dropped their target price on shares of Pfizer from $27.00 to $26.00 and set a “neutral” rating for the company in a research report on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, fourteen have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Pfizer has a consensus rating of “Hold” and an average target price of $28.28.

Check Out Our Latest Stock Report on PFE Pfizer Price Performance Pfizer stock opened at $28.00 on Friday. The company has a current ratio of 1.27, a quick ratio of 0.96 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $159.59 billion, a P/E ratio of 36.84 and a beta of 0.34. The business has a 50-day moving average of $25.30 and a 200-day moving average of $26.25. Pfizer Inc. has a 1 year low of $23.58 and a 1 year high of $28.75.

Pfizer (NYSE:PFE – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The biopharmaceutical company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.68 by $0.09. Pfizer had a net margin of 6.80% and a return on equity of 19.63%. The business had revenue of $15.03 billion for the quarter, compared to the consensus estimate of $14.40 billion. During the same period last year, the company posted $0.78 EPS. Pfizer’s revenue for the quarter was up 2.6% on a year-over-year basis. Pfizer has set its FY 2026 guidance at 2.800-3.000 EPS. On average, equities analysts anticipate that Pfizer Inc. will post 2.98 EPS for the current year.

Pfizer Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Friday, July 24th will be issued a $0.43 dividend. The ex-dividend date is Friday, July 24th. This represents a $1.72 annualized dividend and a yield of 6.1%. Pfizer’s dividend payout ratio (DPR) is 226.32%.

Trending Headlines about Pfizer Here are the key news stories impacting Pfizer this week:

Positive Sentiment: Pfizer completed a Phase 1/2 study of PF-07868489, an experimental treatment for pulmonary arterial hypertension. The milestone supports early-stage pipeline progress, though additional clinical testing will be needed before any potential commercialization. Pfizer’s PF-07868489 PAH Study Reaches Completion Positive Sentiment: Several additional clinical updates highlighted progress across Pfizer’s development portfolio: completion of a Phase 1 atirmociclib study, completion of a drug-interaction study for PF-07248144, and a new Phase 1 liver study for atirmociclib. These milestones may reinforce confidence in Pfizer’s ability to replenish revenue as older products face competition. Atirmociclib Study Update PF-07248144 Study Update Positive Sentiment: Pfizer is also expanding real-world evidence efforts for prostate cancer therapies, Ibrance in advanced breast cancer, and a migraine treatment study in India. These studies could support broader use and strengthen commercial evidence for existing medicines. Pfizer Real-World Prostate Cancer Study Positive Sentiment: Investor-oriented coverage remains constructive, citing Pfizer’s roughly 19% year-to-date gain, attractive dividend yield, and reported hedge-fund buying. The stock’s move toward its 52-week high suggests improving sentiment. Hedge Funds Buying Pfizer Neutral Sentiment: Unusually large options activity may increase short-term trading interest, but it does not establish a clear fundamental direction for PFE. Pfizer Options Trading Negative Sentiment: Coverage of settlements involving thousands of Depo-Provera lawsuits raises concerns about potential legal costs and ongoing liability. Analysts also continue to weigh whether new drugs and acquisitions can offset revenue losses from expiring patents. Pfizer Legal Claims About Pfizer (Free Report)

Pfizer Inc (NYSE: PFE) is a multinational biopharmaceutical company headquartered in New York City. Founded in 1849 by Charles Pfizer and Charles Erhart, the company researches, develops, manufactures and commercializes a broad range of medicines and vaccines for human health. Its activities span discovery research, clinical development, regulatory affairs, manufacturing and global commercial distribution across multiple therapeutic areas.

Pfizer’s portfolio and pipeline cover oncology, immunology, cardiology, endocrinology, rare diseases, hospital acute care and anti-infectives, along with a substantial vaccine business.

Read More Five stocks we like better than Pfizer 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit? Want to see what other hedge funds are holding PFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pfizer Inc. (NYSE:PFE – Free Report).

Receive News & Ratings for Pfizer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pfizer and related companies with MarketBeat.com's FREE daily email newsletter.

111 Capital purchased a new stake in Merck & Co., Inc. (NYSE:MRK – Free Report) during the second quarter, according to its most recent filing with the SEC. The firm purchased 4,582 shares of the company’s stock, valued at approximately $589,000.

Several other hedge funds also recently bought and sold shares of the company. Kingdom Financial Group LLC. acquired a new stake in Merck & Co., Inc. during the 4th quarter worth $25,000. Abound Financial LLC bought a new position in Merck & Co., Inc. during the fourth quarter worth about $26,000. Prosperity Bancshares Inc acquired a new position in Merck & Co., Inc. in the fourth quarter valued at about $26,000. High Note Wealth LLC grew its stake in Merck & Co., Inc. by 58.9% in the fourth quarter. High Note Wealth LLC now owns 294 shares of the company’s stock valued at $31,000 after acquiring an additional 109 shares during the period. Finally, IFC & Insurance Marketing Inc. acquired a new position in Merck & Co., Inc. in the fourth quarter valued at about $31,000. 76.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Merck & Co., Inc. In other news, EVP Chirfi Guindo sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 13th. The shares were sold at an average price of $135.00, for a total transaction of $1,350,000.00. Following the transaction, the executive vice president directly owned 36,613 shares of the company’s stock, valued at approximately $4,942,755. This trade represents a 21.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP David R. Maraldo sold 18,706 shares of Merck & Co., Inc. stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $128.72, for a total transaction of $2,407,836.32. Following the completion of the sale, the executive vice president owned 18,212 shares of the company’s stock, valued at approximately $2,344,248.64. The trade was a 50.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 228,238 shares of company stock valued at $29,977,783. 0.17% of the stock is currently owned by insiders.

More Merck & Co., Inc. News Here are the key news stories impacting Merck & Co., Inc. this week: Positive Sentiment: Merck and Moderna reported that their personalized cancer therapy met key Phase 3 goals, improving recurrence-free and distant metastasis-free survival for high-risk melanoma patients when added to Keytruda. The result is the first major late-stage win for an mRNA cancer vaccine and strengthens the potential for regulatory approval and broader oncology applications. MRK/MRNA’s Personalized Cancer Therapy Delivers First Phase III Win Positive Sentiment: Several Wall Street firms raised their outlooks for MRK: Goldman Sachs increased its price target to $160 and kept a Buy rating, while BMO raised its target to $170 and UBS lifted its target to $175. Morgan Stanley also upgraded the shares to Overweight with a $179 target after the cancer-trial success. Positive Sentiment: Investors see Merck’s newer products, acquired assets and pipeline programs as a potential growth cushion against Keytruda’s eventual patent expiration. The company’s expanding portfolio could help diversify revenue beyond its flagship drug. Can Merck’s New Drugs Offer Growth Cushion Ahead of Keytruda LOE? Neutral Sentiment: Unusually high options activity indicates heightened investor interest and potential volatility, but it does not by itself establish the direction of the stock. Negative Sentiment: RBC Capital Markets downgraded Merck to Sector Perform and set a $150 target, arguing that execution risks and the 2028 Keytruda loss of exclusivity are being underestimated. RBC said near-term catalysts are attractive, but the stock’s valuation leaves limited room for additional gains. Merck upgraded at Morgan Stanley after cancer trial win; RBC downgrades Negative Sentiment: Jefferies separately moved Merck from Strong Buy to Hold. The central concern is that the shares have already rallied substantially on the trial news, making the current valuation appear demanding relative to the remaining patent and execution risks. Merck & Co., Inc. Stock Up 2.3% MRK stock opened at $152.43 on Friday. Merck & Co., Inc. has a twelve month low of $77.58 and a twelve month high of $154.49. The company has a quick ratio of 1.10, a current ratio of 1.32 and a debt-to-equity ratio of 1.22. The business has a 50 day moving average price of $128.09 and a two-hundred day moving average price of $121.23. The company has a market cap of $376.07 billion, a price-to-earnings ratio of 121.94, a P/E/G ratio of 6.58 and a beta of 0.19.

Merck & Co., Inc. (NYSE:MRK – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.13. Merck & Co., Inc. had a net margin of 4.77% and a return on equity of 16.73%. The business had revenue of $16.61 billion during the quarter, compared to the consensus estimate of $16.37 billion. During the same period last year, the business posted $2.13 EPS. Merck & Co., Inc.’s revenue was up 5.1% on a year-over-year basis. Merck & Co., Inc. has set its FY 2026 guidance at 2.660-2.760 EPS. Analysts anticipate that Merck & Co., Inc. will post 2.76 EPS for the current fiscal year.

Merck & Co., Inc. Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 7th. Stockholders of record on Tuesday, September 15th will be issued a dividend of $0.85 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $3.40 dividend on an annualized basis and a dividend yield of 2.2%. Merck & Co., Inc.’s dividend payout ratio (DPR) is currently 272.00%.

Analyst Ratings Changes MRK has been the topic of a number of research analyst reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $120.00 price target on shares of Merck & Co., Inc. in a research report on Monday, July 6th. Jefferies Financial Group lowered Merck & Co., Inc. from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Citigroup began coverage on Merck & Co., Inc. in a research note on Wednesday, May 6th. They set a “neutral” rating and a $125.00 target price for the company. JPMorgan Chase & Co. raised their target price on shares of Merck & Co., Inc. from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Finally, Weiss Ratings lowered shares of Merck & Co., Inc. from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, August 11th. Fifteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, Merck & Co., Inc. presently has an average rating of “Moderate Buy” and a consensus price target of $144.10.

Get Our Latest Stock Analysis on Merck & Co., Inc.

About Merck & Co., Inc. (Free Report)

Merck & Co, Inc is a global biopharmaceutical company engaged in the discovery, development, manufacture and marketing of prescription medicines, vaccines, biologic therapies and animal health products. Its portfolio spans multiple therapeutic areas with a particular emphasis on oncology, vaccines and infectious disease, as well as therapies for metabolic and chronic conditions. Among its well-known products are the cancer immunotherapy Keytruda (pembrolizumab) and the human papillomavirus vaccine Gardasil; the company also markets a range of medicines and vaccines for veterinary use through Merck Animal Health.

Founded in the late 19th century as the U.S.

Featured Stories Five stocks we like better than Merck & Co., Inc. 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Merck & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Callan Family Office LLC bought a new position in shares of Newmont Corporation (NYSE:NEM – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 32,059 shares of the basic materials company’s stock, valued at approximately $2,994,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. BlackRock Inc. bought a new position in shares of Newmont in the 2nd quarter worth $11,289,753,000. Norges Bank bought a new stake in Newmont in the fourth quarter valued at about $1,443,128,000. Bank of New York Mellon Corp bought a new stake in Newmont in the second quarter valued at about $1,219,505,000. Deutsche Bank AG acquired a new position in Newmont in the second quarter valued at about $911,180,000. Finally, Van ECK Associates Corp boosted its holdings in Newmont by 23.4% during the fourth quarter. Van ECK Associates Corp now owns 29,780,063 shares of the basic materials company’s stock worth $2,973,539,000 after buying an additional 5,643,496 shares during the last quarter. Institutional investors own 68.85% of the company’s stock.

Wall Street Analyst Weigh In A number of analysts have recently commented on NEM shares. Raymond James Financial lowered their price target on Newmont from $139.00 to $137.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. National Bank Financial reduced their price objective on shares of Newmont from $140.00 to $125.00 and set a “sector perform” rating on the stock in a research note on Tuesday, July 14th. Canaccord Genuity Group decreased their price objective on shares of Newmont from $160.00 to $130.00 and set a “buy” rating for the company in a report on Thursday, July 23rd. TD Cowen reaffirmed a “buy” rating on shares of Newmont in a research note on Monday, April 27th. Finally, UBS Group cut their target price on shares of Newmont from $140.00 to $120.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. Two analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $132.59.

Get Our Latest Report on Newmont Newmont Stock Up 3.2% NYSE:NEM opened at $131.76 on Friday. Newmont Corporation has a 1 year low of $69.05 and a 1 year high of $134.88. The stock has a 50-day moving average price of $101.60 and a two-hundred day moving average price of $108.96. The stock has a market cap of $138.83 billion, a price-to-earnings ratio of 16.64, a PEG ratio of 1.36 and a beta of 0.47. The company has a current ratio of 2.55, a quick ratio of 2.26 and a debt-to-equity ratio of 0.15.

Newmont (NYSE:NEM – Get Free Report) last released its quarterly earnings results on Thursday, July 23rd. The basic materials company reported $2.10 EPS for the quarter, topping analysts’ consensus estimates of $2.05 by $0.05. Newmont had a return on equity of 29.10% and a net margin of 33.36%.The company had revenue of $6.12 billion for the quarter, compared to analyst estimates of $6.35 billion. During the same quarter last year, the firm posted $1.43 earnings per share. As a group, equities analysts expect that Newmont Corporation will post 9.01 earnings per share for the current year.

Newmont Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Monday, September 28th. Investors of record on Thursday, September 3rd will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Thursday, September 3rd. Newmont’s dividend payout ratio is presently 13.13%.

Insiders Place Their Bets In other Newmont news, CFO Brian Tabolt sold 11,445 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $105.09, for a total transaction of $1,202,755.05. Following the sale, the chief financial officer directly owned 29,324 shares in the company, valued at approximately $3,081,659.16. This trade represents a 28.07% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Peter Toth sold 3,000 shares of Newmont stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $93.45, for a total transaction of $280,350.00. Following the completion of the transaction, the executive vice president directly owned 40,315 shares in the company, valued at approximately $3,767,436.75. The trade was a 6.93% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 32,091 shares of company stock worth $3,292,513. Company insiders own 0.06% of the company’s stock.

Key Stories Impacting Newmont Here are the key news stories impacting Newmont this week:

Positive Sentiment: Gold reached record levels. Spot gold traded above $4,500 an ounce and was on track for a third consecutive weekly gain. A softer U.S. dollar, bond-market volatility and inflation concerns increased demand for gold as a safe-haven asset, improving the potential revenue and cash-flow outlook for Newmont. Why Is Newmont Stock Surging Friday? Positive Sentiment: Strong operating performance and capital returns supported sentiment. Newmont reported record second-quarter free cash flow of $2.2 billion and operating cash flow of $2.9 billion, remains on track to produce 5.3 million attributable gold ounces in 2026, and has returned approximately $1.9 billion through dividends and share repurchases since its prior earnings report. Positive Sentiment: Scotiabank raised its earnings forecast. The firm increased its FY2026 EPS estimate to $8.96 from $8.83, maintained an “Outperform” rating and set a $149 price target. The median target among 10 analysts is reported at $145.50, suggesting analysts generally see additional upside. Neutral Sentiment: Newmont appointed Peter Beaven as an independent director. Effective September 1, Beaven is expected to join the Audit Committee, adding finance and global mining experience. The appointment is strategically supportive but is unlikely to materially change near-term earnings. Newmont Appoints Peter Beaven to Board of Directors Neutral Sentiment: Newmont agreed to sell a Nevada gold project to StrikePoint for $70 million. The transaction may help streamline the portfolio and monetize a noncore asset, although the immediate earnings impact was not provided. StrikePoint to Buy Nevada Gold Project from Newmont Negative Sentiment: Reported insider trading was a potential cautionary signal. Company insiders recorded 15 open-market sales and no purchases during the past six months, though such transactions may reflect compensation or personal financial planning rather than a view on Newmont’s business. Newmont Company Profile (Free Report)

Newmont Corporation (NYSE: NEM) is a leading global gold mining company engaged in the exploration, development, processing and reclamation of gold properties. The company’s core business centers on the production of gold, with additional byproduct metals produced from its operations. Newmont operates a portfolio of long‑lived mines and development projects, and its activities span the full mine life cycle from early-stage exploration through to mining, milling and closure.

Founded in 1921 and headquartered in Greenwood Village, Colorado, Newmont has grown through organic development and strategic acquisitions.

Further Reading Five stocks we like better than Newmont 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Newmont Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newmont and related companies with MarketBeat.com's FREE daily email newsletter.

EP Wealth Advisors LLC acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,122 shares of the semiconductor company’s stock, valued at approximately $3,177,000.

Other institutional investors have also modified their holdings of the company. Sankala Group LLC purchased a new position in shares of Synopsys in the 4th quarter worth approximately $25,000. Elevation Wealth Partners LLC raised its holdings in Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 27 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in Synopsys during the 4th quarter valued at $28,000. IMG Wealth Management Inc. bought a new stake in Synopsys in the second quarter worth $28,000. Finally, Atlas Capital Advisors Inc. bought a new stake in Synopsys in the fourth quarter worth $32,000. 85.47% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth Several research analysts have commented on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Morgan Stanley reduced their target price on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Bank of America raised their target price on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Citigroup lifted their price target on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, KeyCorp reiterated an “overweight” rating on shares of Synopsys in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $563.59.

Check Out Our Latest Analysis on Synopsys Insiders Place Their Bets In related news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by insiders.

Synopsys Price Performance SNPS opened at $397.87 on Friday. The business has a fifty day moving average of $419.73 and a 200 day moving average of $440.22. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $615.79. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock has a market cap of $76.18 billion, a P/E ratio of 92.10, a PEG ratio of 2.34 and a beta of 1.23.

Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the prior year, the company posted $3.67 EPS. Synopsys’s quarterly revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.

About Synopsys (Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More Five stocks we like better than Synopsys 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.

Equity Investment Corp bought a new stake in Wells Fargo & Company (NYSE:WFC) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,504,825 shares of the financial services provider’s stock, valued at approximately $124,359,000. Wells Fargo & Company comprises 2.4% of Equity Investment Corp’s portfolio, making the stock its 17th largest position.

Several other institutional investors have also recently bought and sold shares of WFC. Aljian Capital Management LLC acquired a new position in Wells Fargo & Company during the second quarter worth about $1,287,000. Meeder Advisory Services Inc. acquired a new stake in shares of Wells Fargo & Company in the 2nd quarter valued at approximately $6,250,000. Meeder Asset Management Inc. acquired a new stake in shares of Wells Fargo & Company in the 2nd quarter valued at approximately $49,000. Pzena Investment Management LLC bought a new stake in shares of Wells Fargo & Company during the 2nd quarter valued at approximately $729,502,000. Finally, Citizens Financial Group Inc. RI bought a new stake in shares of Wells Fargo & Company during the 2nd quarter valued at approximately $25,922,000. Institutional investors and hedge funds own 75.90% of the company’s stock.

Analyst Ratings Changes A number of equities analysts recently issued reports on the stock. Keefe, Bruyette & Woods lowered their price objective on shares of Wells Fargo & Company from $98.00 to $94.00 and set a “market perform” rating for the company in a research report on Wednesday, July 15th. Raymond James Financial restated a “market perform” rating on shares of Wells Fargo & Company in a research report on Tuesday, July 14th. Phillip Securities raised shares of Wells Fargo & Company from a “moderate buy” rating to a “strong-buy” rating in a research note on Thursday, May 7th. UBS Group lowered their price target on shares of Wells Fargo & Company from $105.00 to $104.00 and set a “buy” rating for the company in a report on Tuesday, July 7th. Finally, Truist Financial increased their price target on Wells Fargo & Company from $90.00 to $94.00 and gave the company a “buy” rating in a research note on Friday, June 26th. Two analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $98.61.

Read Our Latest Research Report on WFC Wells Fargo & Company Stock Performance NYSE:WFC opened at $83.83 on Friday. The stock’s 50-day moving average is $86.08 and its 200-day moving average is $82.97. Wells Fargo & Company has a 1-year low of $72.78 and a 1-year high of $97.76. The company has a current ratio of 0.90, a quick ratio of 0.90 and a debt-to-equity ratio of 1.09. The stock has a market cap of $253.50 billion, a P/E ratio of 12.18, a price-to-earnings-growth ratio of 0.91 and a beta of 0.92.

Wells Fargo & Company (NYSE:WFC – Get Free Report) last issued its quarterly earnings data on Tuesday, July 14th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.23. Wells Fargo & Company had a net margin of 17.55% and a return on equity of 13.85%. The business had revenue of $22.62 billion during the quarter, compared to analyst estimates of $21.86 billion. During the same quarter last year, the business earned $1.60 EPS. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. Equities research analysts anticipate that Wells Fargo & Company will post 7.26 earnings per share for the current year.

Wells Fargo & Company Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Friday, August 7th will be given a $0.50 dividend. This is an increase from Wells Fargo & Company’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, August 7th. This represents a $2.00 annualized dividend and a yield of 2.4%. Wells Fargo & Company’s dividend payout ratio is currently 29.07%.

Wells Fargo & Company Profile (Free Report)

Wells Fargo & Company is a diversified, U.S.-based financial services company headquartered in San Francisco, California. Founded in 1852 by Henry Wells and William G. Fargo, the firm has evolved from its origins in express delivery and pioneer-era banking into one of the largest full-service banks in the United States. The company provides a broad range of financial products and services to individual, small business, commercial, and institutional clients. Charles W. Scharf serves as chief executive officer.

Wells Fargo operates across several core business segments, including consumer banking and lending, commercial banking, corporate and investment banking, and wealth and investment management.

Featured Articles Five stocks we like better than Wells Fargo & Company 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit? Want to see what other hedge funds are holding WFC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Wells Fargo & Company (NYSE:WFC – Free Report).

Receive News & Ratings for Wells Fargo & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wells Fargo & Company and related companies with MarketBeat.com's FREE daily email newsletter.

Acumen Wealth Advisors LLC grew its position in shares of Micron Technology, Inc. (NASDAQ:MU – Free Report) by 165.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,831 shares of the semiconductor manufacturer’s stock after buying an additional 5,498 shares during the period. Micron Technology makes up 2.2% of Acumen Wealth Advisors LLC’s holdings, making the stock its 13th biggest position. Acumen Wealth Advisors LLC’s holdings in Micron Technology were worth $10,194,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. High Note Wealth LLC increased its holdings in shares of Micron Technology by 65.4% during the fourth quarter. High Note Wealth LLC now owns 86 shares of the semiconductor manufacturer’s stock worth $25,000 after purchasing an additional 34 shares during the period. Kohmann Bosshard Financial Services LLC acquired a new position in Micron Technology in the 1st quarter valued at $27,000. Bayban bought a new stake in shares of Micron Technology during the 4th quarter valued at $29,000. Joseph Group Capital Management bought a new stake in shares of Micron Technology during the 4th quarter valued at $31,000. Finally, Luken Investment Analytics LLC acquired a new stake in shares of Micron Technology during the 4th quarter worth $31,000. Institutional investors and hedge funds own 80.84% of the company’s stock.

Micron Technology Price Performance Shares of MU stock opened at $966.78 on Friday. The company has a quick ratio of 2.98, a current ratio of 3.42 and a debt-to-equity ratio of 0.05. Micron Technology, Inc. has a twelve month low of $114.25 and a twelve month high of $1,255.00. The company has a market cap of $1.09 trillion, a P/E ratio of 21.89 and a beta of 2.18. The business has a fifty day simple moving average of $967.02 and a 200 day simple moving average of $696.28.

Micron Technology (NASDAQ:MU – Get Free Report) last released its earnings results on Wednesday, June 24th. The semiconductor manufacturer reported $25.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $21.39 by $3.72. The firm had revenue of $41.46 billion for the quarter, compared to analysts’ expectations of $35.91 billion. Micron Technology had a return on equity of 71.13% and a net margin of 55.91%.The business’s revenue for the quarter was up 345.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.91 earnings per share. Micron Technology has set its Q4 2026 guidance at 30.000-32.000 EPS. On average, sell-side analysts forecast that Micron Technology, Inc. will post 72.93 EPS for the current fiscal year. Micron Technology Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Tuesday, July 21st. Shareholders of record on Monday, July 6th were given a $0.15 dividend. The ex-dividend date was Monday, July 6th. This represents a $0.60 dividend on an annualized basis and a yield of 0.1%. Micron Technology’s dividend payout ratio (DPR) is currently 1.36%.

Wall Street Analyst Weigh In A number of research analysts recently commented on MU shares. New Street Research upgraded Micron Technology from a “neutral” rating to a “buy” rating and set a $1,250.00 price target on the stock in a research report on Friday, August 14th. Wolfe Research set a $1,500.00 price objective on shares of Micron Technology in a research report on Thursday, June 25th. Morgan Stanley increased their price objective on shares of Micron Technology from $1,050.00 to $1,200.00 and gave the stock an “overweight” rating in a research note on Thursday, June 25th. Mizuho raised their target price on shares of Micron Technology from $1,150.00 to $1,375.00 and gave the company an “outperform” rating in a report on Thursday, June 25th. Finally, Royal Bank Of Canada boosted their target price on shares of Micron Technology from $1,200.00 to $1,500.00 and gave the company an “outperform” rating in a research report on Thursday, June 25th. Four equities research analysts have rated the stock with a Strong Buy rating, thirty-two have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $1,261.26.

Read Our Latest Report on MU

Insider Activity In other Micron Technology news, CAO Scott R. Allen sold 879 shares of the business’s stock in a transaction on Thursday, July 23rd. The shares were sold at an average price of $1,000.00, for a total transaction of $879,000.00. Following the sale, the chief accounting officer owned 34,958 shares of the company’s stock, valued at approximately $34,958,000. The trade was a 2.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Lynn A. Dugle sold 1,300 shares of the company’s stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of $1,150.43, for a total transaction of $1,495,559.00. Following the transaction, the director owned 17,728 shares of the company’s stock, valued at $20,394,823.04. This trade represents a 6.83% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 177,179 shares of company stock valued at $181,826,211. 0.24% of the stock is currently owned by insiders.

Micron Technology News Roundup Here are the key news stories impacting Micron Technology this week:

Positive Sentiment: $10 billion research commitment: Micron unveiled Micron Research Labs in Boise, backed by a planned $10 billion investment over the next decade. The facility will focus on memory, advanced packaging, computing systems and future semiconductor manufacturing, potentially strengthening Micron’s position in AI infrastructure. Micron Research Labs announcement Positive Sentiment: Strong AI demand outlook: CEO Sanjay Mehrotra said AI has fundamentally changed the traditional boom-and-bust memory cycle and that AI systems cannot scale without memory. Tight supply and demand for high-bandwidth memory, server DRAM and data-center products remain key bullish catalysts. Micron CEO AI demand comments Positive Sentiment: Upbeat analyst coverage: BMO Capital Markets initiated coverage with an “outperform” rating and a $1,300 price target. Separately, D.A. Davidson analyst Gil Luria reportedly raised his target to $2,000, keeping a Buy rating. These forecasts suggest analysts expect AI-driven memory pricing and earnings to support further gains. Micron price target commentary Positive Sentiment: Positive sector momentum: Strong demand and SK hynix’s $28.6 billion buyback are supporting confidence across memory stocks. Investors are also watching Nvidia’s upcoming earnings for evidence that AI infrastructure spending remains robust. Nvidia and Micron AI outlook Neutral Sentiment: Long-term expansion versus execution risk: Micron’s broader $50 billion Idaho manufacturing buildout should increase U.S. capacity and support future growth, but the scale of the spending raises capital-allocation, construction and execution risks. Negative Sentiment: Valuation and cyclicality concerns: Commentary warns that Micron’s record revenue has been driven primarily by higher memory prices rather than substantial shipment growth. Bears argue that memory remains cyclical and that AI optimism may already be reflected in the stock’s substantial prior rally. Micron memory price analysis Negative Sentiment: Market and analyst pressure: Rising Treasury yields have weighed on growth stocks, while Zacks Research downgraded Micron from “strong buy” to “hold.” Michael Burry’s warning that AI infrastructure may contain excessive leverage adds to broader sector risk. Negative Sentiment: Insider and institutional selling: EVP Sumit Sadana sold 15,000 shares for approximately $14 million, and Stanley Druckenmiller’s fund reportedly exited Micron during the second quarter. Neither transaction necessarily signals deteriorating fundamentals, but both can reinforce profit-taking concerns after the sharp advance. Micron insider sale Negative Sentiment: No near-term buyback: Micron is prioritizing large investments and cannot immediately match rivals’ aggressive repurchases, reducing a potential source of near-term shareholder support. Micron buyback analysis (Free Report)

Micron Technology, Inc is a global semiconductor company that designs and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, solid-state drives (SSDs), memory modules and embedded memory solutions for a wide range of computing and electronic devices. Micron supplies components used in data centers, enterprise and cloud infrastructure, client computing, mobile devices, automotive systems and industrial applications, and also markets consumer-facing products under the Crucial brand.

Founded in 1978 and headquartered in Boise, Idaho, Micron has grown into an international manufacturer with research, development and production facilities across multiple regions.

Featured Articles Five stocks we like better than Micron Technology 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit? Want to see what other hedge funds are holding MU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Micron Technology, Inc. (NASDAQ:MU – Free Report).

Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.

D.A. Davidson & CO. trimmed its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 20.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 148,208 shares of the healthcare product maker’s stock after selling 38,578 shares during the quarter. D.A. Davidson & CO.’s holdings in Abbott Laboratories were worth $13,448,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of ABT. MidAtlantic Capital Management Inc. purchased a new position in shares of Abbott Laboratories in the fourth quarter worth $25,000. Cornerstone Financial Management LLC purchased a new stake in Abbott Laboratories during the 4th quarter valued at $25,000. Purpose Unlimited Inc. bought a new stake in Abbott Laboratories in the 4th quarter worth $25,000. Portfolio Resources Advisor Group Inc. purchased a new position in shares of Abbott Laboratories in the fourth quarter valued at about $26,000. Finally, Abound Financial LLC bought a new position in shares of Abbott Laboratories during the fourth quarter valued at about $26,000. Institutional investors own 75.18% of the company’s stock.

Abbott Laboratories News Summary Here are the key news stories impacting Abbott Laboratories this week:

Positive Sentiment: Abbott’s Instinct continuous glucose sensor is now commercially shipping in the U.S. integrated with MiniMed’s Flex automated insulin-delivery system. The partnership expands Abbott’s presence in diabetes technology and could support sensor adoption and recurring revenue. MiniMed Ships MiniMed Flex With Abbott’s Smallest Instinct Sensor Positive Sentiment: Abbott also entered a multiyear agreement with HealthTab to distribute its Afinion 2 point-of-care analyzers through NHS-linked pharmacies in the United Kingdom. The deal may broaden access to Abbott’s HbA1c and lipid-testing products, although financial details were not disclosed. HealthTab Enters Multi-Year Collaboration Agreement with Abbott Neutral Sentiment: Abbott agreed to pay approximately $670 million to resolve the Gill case and claims from roughly 2,000 individuals involving specialty formulas for premature infants. The settlement resolves a portion of the litigation, including the appeal of a prior $495 million verdict, reducing uncertainty and potentially avoiding additional legal costs. Abbott denied that its products cause necrotizing enterocolitis and said regulators and medical professionals consider the formulas safe and necessary. Abbott agrees to $670 million settlement of infant formula cases Negative Sentiment: The settlement represents a significant cash and earnings cost and does not resolve all potential litigation related to the infant formulas. Investors may continue to assess the scope of remaining claims and the effect on Abbott’s legal reserves and profitability. Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas Analyst Ratings Changes Several research firms recently issued reports on ABT. Royal Bank Of Canada reissued an “outperform” rating and issued a $130.00 target price on shares of Abbott Laboratories in a research note on Friday, July 17th. Robert W. Baird started coverage on Abbott Laboratories in a report on Wednesday, July 1st. They issued an “outperform” rating and a $121.00 price objective for the company. Piper Sandler reiterated an “overweight” rating and issued a $118.00 price objective (up from $115.00) on shares of Abbott Laboratories in a research report on Friday, July 17th. Citigroup upped their target price on Abbott Laboratories from $108.00 to $112.00 and gave the company a “buy” rating in a report on Friday, July 17th. Finally, Weiss Ratings upgraded shares of Abbott Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, August 6th. Three investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Abbott Laboratories has an average rating of “Moderate Buy” and an average target price of $118.67. Get Our Latest Analysis on Abbott Laboratories

Abbott Laboratories Stock Up 2.2% Shares of NYSE:ABT opened at $116.62 on Friday. The company has a current ratio of 1.38, a quick ratio of 0.97 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $201.80 billion, a price-to-earnings ratio of 37.74, a PEG ratio of 2.26 and a beta of 0.59. Abbott Laboratories has a 12-month low of $81.97 and a 12-month high of $137.49. The stock has a fifty day simple moving average of $100.08 and a two-hundred day simple moving average of $100.05.

Abbott Laboratories (NYSE:ABT – Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The healthcare product maker reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.03. Abbott Laboratories had a net margin of 11.65% and a return on equity of 17.69%. The firm had revenue of $12.59 billion for the quarter, compared to analysts’ expectations of $12.52 billion. During the same quarter in the prior year, the company posted $1.26 earnings per share. The business’s revenue for the quarter was up 13.0% on a year-over-year basis. Abbott Laboratories has set its Q3 2026 guidance at 1.380-1.46 EPS and its FY 2026 guidance at 5.450-5.60 EPS. On average, research analysts anticipate that Abbott Laboratories will post 5.52 earnings per share for the current fiscal year.

Abbott Laboratories Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Monday, August 17th. Stockholders of record on Wednesday, July 15th were issued a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, July 15th. Abbott Laboratories’s dividend payout ratio is presently 81.55%.

Abbott Laboratories Company Profile (Free Report)

Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, that develops, manufactures and markets a broad portfolio of medical products and services. Founded in 1888, Abbott operates through multiple business areas that focus on diagnostics, medical devices, nutritionals and established pharmaceuticals. The company supplies hospitals, clinics, laboratories, retailers and direct-to-consumer channels with products intended to diagnose, treat and manage a wide range of health conditions.

In diagnostics, Abbott provides laboratory and point-of-care testing platforms and assays used to detect infectious diseases, chronic conditions and biomarkers; its Alinity family of instruments and rapid-test solutions are examples of this capability.

See Also Five stocks we like better than Abbott Laboratories 2 Biotech Stocks Shaping Up for Major Breakouts 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit? Want to see what other hedge funds are holding ABT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abbott Laboratories (NYSE:ABT – Free Report).

Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.